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              Due to the crucial antioxidant role of Thioredoxin (Trx) system in various vital 
cellular processes; DNA synthesis, oxidative stress defense, protein folding, apoptosis 
and cell growth, this fundamental system is widely expressed in mostly all life’s 
kingdoms. Thus using metagenomic approaches to characterize novel Trx system in 
unexplored harsh environment will open the window for understanding the evolution of 
Trx system and its unique adaptation in extreme habitations. One of the unexplored 
unique ecosystems is the Red Sea’s Atalntis II brine pool, specifically, the lower 
convective layer (LCL). The exceptional harsh conditions of the LCL; anoxic condition, 
high temperature around 70°C, high salinity (26%), and high metal content, have a 
significant contribution for being a unique infrequent ecosystem.  
 
The objective of this study is to characterize a novel Trx isolated from the LCL. 
Successfully, in the experimental part, Trx was expressed in E. coli and purified, where 
the purified Trx has shown a clear antioxidant activity with a unique 
thermohalophilicity.  
 
In conclusion, we have characterized a unique antioxidant Trx protein.  
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Chapter 1: Literature Review 
1. Red Sea; The Unique Ecosystem 
The Red Sea has different names in different languages; Al Baḥr Al Aḥmar in 
Arabic, Mare Rubrum in Latin (which means Arabian Gulf or Sinus Arabicus), while in 
the Greek language known as Erythra Thalassa. Interestingly, the Red Sea has got its 
name from the changes in color observed in its waters. Typically, the Red Sea has an 
intense blue-green color; however, it is inhabited by extensive blooms of sea sawdust 
(Trichodesmium erythraeum algae) at the sea surface that upon dying off, turn the color 
of the sea to a reddish brown color6.  The Red Sea was formed about 5 million years ago 
due to the split of the African and Arabian plates. It is located between the Asian and 
African continent, where it is bordered by eight countries; Kingdom of Saudi Arabia, 
Egypt, Sudan, Jordan, Yemen, Eritrea, Djibouti and Israel as shown in Figure 1.  
 
Adopted from http://www.coral-reef-info.com/red-sea-coral-reefs 
Figure 1: Map of the Red Sea 
The Red Sea is located between the Asian and African continent, where it is bordered by eight 
countries; Kingdom of Saudi Arabia, Egypt, Sudan, Jordan, Yemen, Eritrea, Djibouti and Israel. 
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Basically, the Red Sea is a narrow strip of water that extends from Egypt at the southeast 
for about 2,000 km towards the Bab el-Mandeb Strait that joins with the Gulf of Aden 
and thereafter with the Arabian Sea. From the geological point of view, the Red Sea 
separates the coasts of Sudan, Egypt and Eritrea at the west, while the coasts of Saudi 
Arabia and Yemen at the east 6 . 
1.1 Red Sea Oceanography 
The surface area of the Red Sea is about 440,000 km² with maximum 
depth of 2.2 km and 2250 km long. The temperature at the surface of the Red 
Sea is ranging from 28 °C to 34 °C, that’s why the Red Sea is considered as one 
of the warmest seas worldwide. In addition, the Red Sea is characterized by its 
high salinity, where it is one of the most saltiest water bodies worldwide 6. 
Actually, there are three main reasons for being dense and of high salinity; 
Firstly, the high evaporation rate (net evaporation rate 1.4 – 2 m yr -1) that is 
coupled with the high temperature of the water’s surface. Secondly, absence of 
substantial rivers that can drain into the Red Sea. Finally, the significant low 
rainfall rate (about 2.36 inch annually).7 
 
1.2     Deep Oceanic Basin        
The Red Sea is characterized by having a deep oceanic basin. This deep 
basin comprises about twenty five brine pools 8, where sequestered hot brines 
occupy these brine pools. Brine pools can be defined as large isolated 
depressions filled with water at the seafloor. The impression of a pool down at 
the seafloor results from the high salinity of the hot brine existing there, leading 
to a denser environment rather than the neighboring water, showing poor 
capacity to blend together. And that is why brine pools could be known as 
submarine lakes. 9 
Basically, the environment at the Red Sea’s bottom is exceptionally unique and 
harsh in terms of oxygen depletion, high salinity, enormously high temperature, 
and heavy metal enrichment. However, there are significant differences between 
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the characteristics of the brine pools of the Red Sea. General speaking, the 
hottest and saltiest brine pools are usually in deep nearby the seafloor 9. 
Furthermore, it is believed that the high temperature of the brine pools of the 
Red Sea is originated from the earth’s tectonic activity, where this activity tends 
to create cracks and fractures at the seafloor sediment, and in turn the deep sea 
water penetrates these fissures as shown in Figure 2.  As a result, the penetrated 
water got heated by the effect of submarine magma and starts to absorb 
minerals. Finally, the convective currents returns back the heated water to the 
seabed surface, forming a distinguishing layer of brine, owing to its high 
density. Stereotypically, the sediments of the brine pools are metal rich; sulfides 
of iron, copper and zinc, in addition to high value metals as gold, cobalt and 
silver. 9, 10 
 
Adopted from http://krse.kaust.edu.sa/spring-2010/research.html 
Figure 2: Tectonic Activity and formation of brine pools 
(1) The confined tectonic activities (2) lead to the formation of fissures, which in turn 
allows the penetration of deep-sea water forming brine pools. (3) The submarine magma 
heats the deep sea water (4) and thus, allows the absorbance of minerals that returned 
back to the seabed sediment by the action of convective currents 9,10. 
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2. Atlantis II Deep brine pool     
There are twenty five diverse brine pools existing at the bottom of the 
Red Sea 8; Atlantis II Deep, Discovery Deep, Chain Deep, Valdivia Deep, Kebrit 
and other brine pools. Each brine pool has its own characteristics in terms of 
salinity, temperature and metal enrichment. In 1965, the first two hydrothermal 
sites within the oceans to be discovered were the Atlantis II Deep and Discovery 
Deep in the Red Sea, where they are located at 21°20‘N between 2000 and 2250 
m depth, additionally, the surface area of Atlantis II Deep and Discovery Deep 
are about 6 x 13 Km and 4 x 3 Km respectively 11 (Figure 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adopted from http://krse.kaust.edu.sa/spring-2010/research.html 
Figure 3:  Atlantis II Deep and Discovery Deep brine pools in the Red 
Sea 
The Red Sea map is showing the location of the Atlantis II deep, which is the largest 
brine pool in the Red Sea till current, and Discovery deep. Basically, both brine pools are 
located at 21°20‘N between 2000 and 2250 m depth. The bottom color legend is showing 
the depth of each brine pool in meters11.  
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During that time the recorded temperatures were 56°C for Atlantis II Deep and 45°C for 
Discovery Deep brine pool 11. Interestingly, from November 1966 to February 1969, the 
measured temperatures for the uniform vertical layers of the Atlantis II brine pool have 
showed an obvious increasing pattern, where the temperature of the lower convective 
layer had increased by 2.7 °C, while the upper convective layer had increased by 5.6 °C 
12. Consequent measurements for the Atlantis II brine pool have demonstrated a 
continuous increase in temperatures, where in 1997 have reached 67.1 °C and by October 
2008 have reached almost 70 °C as per KAUST (King Abdullah University for Science 
and Technology) Red Sea expedition in fall 2008. 9, 11 That is to say, the temperature of 
the Atlantis II Deep has increased 14 °C within 43 years, with an approximate rate of 0.3 
°C increment per year 11. Table 1 is showing temperatures and salinity for different layers 
of Atlantis II Deep and Discovery Deep. 
 
Table 1: Different parameters for Atlantis II and Discovery Deep brine pools 
measured in 2008 11.  
 
 Atlantis II Deep Discovery Deep 
  
Temperature 
(ᵒC) 
Salinity 
(psu) 
Interface 
depth (m) 
Temperature 
(ᵒC) 
Interface 
depth (m) 
LCL     68.28 252 2048 44.99 2059 
UCL1  57.32 162 2027     
UCL2 51.25 118 2013     
UCL3 47.98 99 2006     
UCL4 43.53 87 2002     
 
From the above table, it is clear that, by going down from the water surface to the seabed, 
the layers of the Atlantis II brine pool are settled as follow: firstly, the upper convective 
layer (UCL), which is composed of four layers; UCL1, UCL2, UCL3 and UCL4, where 
UCL4 is at depth of 2002 m while UCL1 is at 2027 m. Secondly, the middle convective 
layer and finally, the lower convective layer (LCL) at the maximum depth of 2,048 m. 
Both temperature and salinity increase by going deeper across the layers of the Atlantis II 
Deep to reach its maximum at the LCL, where temperature is about 68.28 ᵒC and salinity 
252 practical salinity unit (psu). On the other hand, the Discovery Deep brine pool is at 
depth of 2059 m, while its temperature is only 44.99 ᵒC 11 
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Practical speaking, Atlantis II brine pool is considered as the biggest brine pool 
existing in the Red Sea, where its surface area is represented by about 60 km2. 
The unique harsh circumstances of the Atlantis II Deep make this environment 
amongst the most infrequent environments existing on Earth 7. The Atlantis II 
brine pool is located at the depth of 2,190 m and segmented into numerous 
vertical convective layers. Both temperature and salinity increase by going 
deeper across the layers of the Atlantis II Deep. By going down from the water 
surface to the seabed, the layers of the Atlantis II brine pool are settled as 
follow: firstly, the upper convective layer (UCL), which is composed of four 
layers; UCL1, UCL2, UCL3 and UCL4, where UCL4 is at depth of 2002 m 
while UCL1 is at 2027 m. Secondly, the middle convective layer and finally, the 
lower convective layer (LCL) at the maximum depth of 2,190 m 11.  
 
In our study, we are much interested in the lowest layer of the Atlantis II brine 
pool. The environment of the LCL has unusual blend of tough conditions; 
extremely high temperature that reaches 68.2°C, salinity of about 26%, which is 
7.5 folds more than that of other seas and its pH value is 5.3 5, 10. Furthermore, 
the LCL of Atlantis II Deep is almost oxygen depleted environment (anoxic) and 
highly enriched with sulfides of iron, zinc, copper and other heavy metals, in 
addition to high value metals as silver, cobalt and gold 9, 10, 11.  That is why; it is 
very attractive spot to understand the structural and functional modifications of 
enzymes and proteins that have been adapted in sake of survival of the microbial 
communities in these harsh abiotic conditions, in addition to the expectation to 
discover novel genes, proteins and metabolic pathways that can be conveniently 
applied in the industry of biotechnology or pharmaceuticals. In this study, we 
have characterized TrxATII in the LCL. 
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3. Thioredoxin System   
 
Due to the crucial antioxidant role of thioredoxin system in various vital cellular 
processes; DNA synthesis, oxidative stress defense, protein folding, apoptosis and cell 
growth, this fundamental system is widely expressed in mostly all life’s kingdoms from 
Archebacteria to higher eukaryotes 1. Basically, Thioredoxin system is comprised of three 
main key players; thioredoxin protein (Trx), thioredoxin reductase enzyme (TrxR) and 
Nicotinamide adenine dinucleotide phosphate co-enzyme (NADPH) as shown in Figure 
4. In this antioxidant system, the role of TrxR is to reduce the oxidized inactive state of 
Trx (comprising a di-sulphide (S-S) bridge) into the reduced active form (comprising 
thiol (SH) groups) through migration of electrons from NADPH to Trx via TrxR. In turn, 
the reduced active Trx can maintain the reduced states of different cellular proteins 
against oxidative stress initiated by different molecules as nitric oxide and hydrogen 
peroxide 2. Furthermore, Thioredoxin system is an essential source of hydrogen for 
numerous reducing enzymes as sulphate reductase, ribonucleotide reductase and 
sulphoxide reductase 3.  
 
Adopted from Physiological functions of thioredoxin and thioredoxin reductase, S. J. Arner and 
A. Holmgren, Eur. J. Biochem. 267, 6102-6109 (2000) 
 
Figure 4: Thioredoxin system 
The schematic figure illustrates the reduction of the disulfide inactive oxidized form of 
thioredoxin (Trx-S2), to the active dithiol reduced form of thioredoxin (Trx-(SH) 2), by 
the action of both thioredoxin reductase (TrxR) and NADPH. Subsequently, Trx-(SH)2 
reduces other oxidized disulfides protein, yielding Trx-S2. Moreover, TrxR may have 
other substrates rather than the homologous Trx to reduce.2, 3 
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3.1 Thioredoxin; The redox protein               
        Thioredoxin (Trx) is a small monomeric redox protein; about 12,000 
Dalton. Trx protein is widely expressed among most species from Archebacteria 
to eukaryotes and humans 1. The reason for being highly conserved among wide 
variety of prokaryotes and eukaryotes is the association of Trx in numerous vital 
cellular processes and functions, including and not limited to, DNA synthesis, 
oxidative stress defense, protein folding, apoptosis and cell growth 13. As a 
redox protein, Trx reduce other intracellular and extracellular oxidized proteins 
comprising disulfide bridge through the exchange of cysteine thiol-disulfide 
bond, where the Trx itself get oxidized forming a disulphide (S-S) bridge as the 
Cysteine residue oxidized to Cystine residue as shown in Figure 5. Further on, 
the oxidized Trx get reduced again forming thiol (SH) groups by the action of 
TrxR at the expense of a molecule of NADPH 13. 
 
    Adopted from http://www.cs.stedwards.edu/chem/Chemistry/CHEM43/CHEM43/Thioredox/FUNCTION.HTML 
 
Figure 5: Disulfide Bridge Exchange  
 
Thioredoxin (Trx) protein is characterized by having a catalytic active motif, which is 
denoted by two vicinal Cysteines that comprise in-between two other amino acids; 
Cysteine-Glycine-Proline-Cysteine (Cys-Gly-Pro-Cys). Upon reducing other oxidized 
proteins, Trx get oxidized, where two Cysteine residues are oxidized to Cystine forming a 
disulfide bridge through the exchange of cysteine thiol-disulfide bond. 14, 17 
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In 1968, the sequence of amino acids of Escherichia coli Trx1 was determined14. 
Basically, on the level of amino acids, all thioredoxins are characterized by 
having a Trx motif, where this redox active catalytic motif is denoted  by 
having two vicinal Cysteines and comprise in-between two other amino acids; 
Cysteine-Glycine-Proline-Cysteine (Cys-Gly-Pro-Cys)14,15,16. This active 
catalytic domain is located near the N-terminal side; C32 XX C35. The conserved 
catalytic site CXXC used to undergo a reversible process of oxidation-reduction 
via the two vicinal Cysteines 17.  In addition to the conserved Trx motif, there is 
a number of amino acids that are highly conserved among the Trx sequence; 
Aspartate 26, Alanine 29, Tryptophan 31, Aspartate 61 and Glycine 92 2 .  
Despite of the various functions of thioredoxins (Trxs) - will be discussed in 
details in the following sections - , all thioredoxins from prokaryotes to 
eukaryotes display a high homology in sequence to the E.coli Trx 1, represented 
by 27 to 69% identity, which is the well characterized protein15, 18. Furthermore, 
thioredoxins are showing the same global three dimensional structure, where 
they comprised the same Trx fold. Basically, the Trx fold is composed of a 
fundamental core of five β-strands that are flanked by four α-helices as shown in 
Figure 6 19. The Cys-Gly-Pro-Cys conserved domain is positioned on the 
surface of the Trx protein, exactly at the terminal of the β-strand and at the start 
of the long α-helix. Around the active catalytic site of Trx, there  is a  
hydrophobic region, which has been proposed to be the central interaction site 
for other oxidized proteins to be reduced 18, 19. Using the Nuclear Magnetic 
Resonance (NMR) spectroscopy, the Trx 3D structure for both forms of E.coli 
Trx; reduced and oxidized have been determined 20. The overall difference 
between the two forms of Trx; reduced and oxidized remains elusive, where 
there is a local conformational change within and round the active disulfide site, 
in addition to more conformational states in  the reduced form of Trx, which is 
reflected on the altered patterns of Hydrogen bonding18, 20. 
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Adopted from Martin, J. Thioredoxin - a fold for all reasons. Structure, 3, 245-250 (1995). 
 
Figure 6:  Thioredoxin Fold 
The position of the helices in relevance to the central -sheet is demonstrated. The  α l and α 3 
helices (grey colored), are located behindhand the sheet in this orientation. On the other hand,  
α 2 helix is located in front of the B-sheet. Moreover, the sites of insertions of other residues are 
signposted by asterisks 19 
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3.2      Thioredoxin System; Prokaryotes versus Mammalians  
 
The mammalian cells are characterized by having a cytosolic thioredoxin 
(Trx1), cytosolic thioredoxin reductase (TrxR), mitochondrial thioredoxin 
(Trx2), mitochondrial thioredoxin reductase (TrxR2), membrane bounded Trx, 
extracellularly Trx and extracellularly truncated Trx (Trx 80) 2 as shown in 
Figure 7.   
 
 
 
Modified from Arner, E. S. and Holmgren, A. Physiological functions of thioredoxin and thioredoxin 
reductase.  Eur. J. Biochem. 267, 6102–6109 (2000).  
 
Figure 7:  Mammalian Thioredoxin System 
This Schematic diagram localizes the presence of thioredoxin (Trx) and thioredoxin 
reductase (TrxR) within the mammalian various cellular compartments; nucleus, 
cytoplasm, membrane bounded and extra-cellularly as follow 2: 
1- Trx and TrxR within the cytoplasm. 
2- Trx and its truncated form (Trx 80) are membrane bounded and extra-cellularly available 
as well. 
3- Mitochondria (Trx2 and TrxR2) 
Truncated form of Trx 
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By comparing the Trx system in prokaryotes to high orders eukaryotes, the most 
significant evolution is in the TrxR, which is a large selenocysteine-enzyme 
(Figure 8) with a broader substrate specificity that shows an obvious variance 
from those smaller TrxR existing in fungi and all bacteria, where the bacterial 
TrxR has narrow substrate specificity as it only reduces the bacterial Trx 21  
 
Adopted from Holmgren, A., Lu, J. Thioredoxin and thioredoxin reductase: Current research 
with special reference to human disease. A. Biochem. & Biophys. Res. Comm. 396, 120–124 
(2010). 
 
Figure 8:  Mammalian Thioredoxin System 
The mammalian thioredoxin redox system composed of thioredoxin (Trx), 
thioredoxin reductase (TrxR), and NADPH. The NADPH is the electron source 
in the Trx system, which is mainly generated from the pentose phosphate 
pathway. The oxidized (Trx-S2) is reduced by the TrxR (Seleno-enzyme) and 
NADPH. Finally, the reduced (Trx-(SH)2) reduces the disulfide bond in various 
proteins. Interestingly, under the oxidative stress conditions, the thioredoxin 
secreted into the plasma, where it can be truncated (Trx80) 21 
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3.3     Redox mechanism of Thioredoxin 
The Cysteine residue at the redox active site located at the N-terminal, 
where it is characterized by having a low pKa value, that is to say, it will act as 
the attacking nucleophile that will reduce the disulfides of other proteins. 
Basically, the oxidoreductase mechanism of Trx comprises two intermediates; a 
transitory disulfide intermediate as well as a fast thiol-disulfide exchange in a 
hydrophobic environment 18. It is a reversible reaction, where Trx either broken 
or form disulfides based on the redox potential of the substrate. The Trx of E. 
coli (Trx1) is characterized by having a low redox potential (-270 mV), which in 
turn guarantees that the reduced form of Trx (Trx-(SH)2) is the main di-thiol 
reducing agent at the cytosol 3. Interestingly, there is a big superfamily of 
proteins, which that comprise one or more domains of Trx. Those proteins with 
the Trx fold are existing in all organisms, where they can be clustered in six 
main classes; Glutathione peroxidases, Thioredoxins, Glutathione transferases, 
Glutaredoxins, Protein disulfide isomerase and bacterial disulfide 
oxidoreductase (DsbA) 19, 22. Actually, the sequence homology among these 
classes is highly limited with almost no common activity, however, there is a 
common functional similarity among the following four classes: Protein 
disulfide isomerases, thioredoxins, DsbA and glutaredoxins, where all of them 
are redox proteins with active catalytic redox motif; -Cys-X1-X2-Cys- (where 
X1 and X2 are any non-Cysteine amino acids). Although, the glutathione 
peroxidases and glutathione transferases classes are missing the active catalytic 
redox motif, they have a specific interaction with glutathione. A recent addition 
to the Trx superfamily is the coined PICOT (protein kinase C-interacting cousin 
of thioredoxin) and the Nucleoredoxin. The coined PICOT which interacts with 
protein kinase C 23 is a larger cytosolic Trx like protein, which has unknown 
clear function 24, 25, while the Nucleoredoxin is a nuclear Trx like protein 
showing an oxido-reductase activity 26. 
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3.4     Role of Thioredoxin system in different organisms  
As being fundamental antioxidant protein expressed in most kingdoms of 
life, Trx has been revealed in at least a dozen of different systems, which is 
evidence to its usefulness in nature. Basically, the common physiological 
function of Trx in most organisms is the essential conserved role as a high-
capacity hydrogen donor system for other reductive enzymes in a magnitude 
faster than those for dithiothreitol (DTT) or glutathione (GSH) 3, 16, with high 
specified functions in phage T7 DNA replication and assembly of filamentous 
phage of Escherichia coli phages. Moreover, the identified role for Trx as a thiol 
redox controller in chloroplast photosynthesis has been also recognized recently 
in redox regulation of transcription factors and enzymes. Additionally, it was 
proven that Trx has vital defensive roles against apoptosis and inactivation or 
aggregation of cytosolic proteins during oxidative stress 2. 
 
The following examples will show the different roles of Trx among most 
organisms of different life’s kingdom; Trx participates in the DNA synthesis by 
acting as a hydrogen donor for ribonucleotide reductase 3, Trx keeps the 
intracellular protein disulfides in the reduced active forms 27, 28, additionally, Trx 
has a fundamental role in signaling pathways as well as defense against 
oxidative stress as being an electron donor for the thioredoxin peroxidases and 
peroxiredoxins that catalyze the reduction of Hydrogen peroxide 29. More 
detailed examples for the different roles of Trx in numerous organisms are 
briefed in Table 2. 
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Table 2: Role of thioredoxin in various organisms 
Organisms Thioredoxin Role Comments 
All Organisms Reduction of  protein disulfides  
 
 
DNA synthesis  
 
Thioredoxin plays a vital role in reducing 
intracellular protein disulfides 14, 28 
 
Thioredoxin is a high capacity hydrogen donor 
for ribonucleotide reductase 3 
 
Many Organisms Reduction of methionine sulfoxide  
 
 
 
Prevent oxidative stress  
 
Thioredoxin is a major hydrogen donor for 
methionine sulfoxide reductases 84, 85 
 
Thioredoxin reduce peroxiredoxins that catalyze 
H2O2 reduction and thus inhibit oxidative stress 
and apoptosis induction29, 35, 86 
 
Bacteria and Yeast Hydrogen donor for 3’-
phosphoadenylsulfate (PAPS) 
reductase 
Assimilation of sulfur by sulfate to sulfite 
reduction 87, 88 
E. coli Phages 
(M13, T7, f1) 
Plays a vital role in filamentous phage 
assembly 
 
 
Subunit of T7 DNA polymerase 
Exclusively, thioredoxin is the merely host E. 
coli protein required for the assembly 
and export of phage 31, 89 
Required for  processivity 90 
 
Plant Regulates the enzymatic photosynthesis 
of chloroplast  
Photosynthesis is regulated by light thru 
ferredoxin 91 
 
Mammalia Pregnancy   
 
 
 
CNS 
 
Birth 
 
Regulation of Apoptosis 
 
 
Redox regulation of transcription 
factors 
Synthesis of thioredoxin from cytotrophoblasts 
takes part in implantation and establishment of 
pregnancy 92, 93, 94 
 
Thioredoxin secreted from glial cells promotes 
neuronal survival at ischemia reperfusion 95 
 
Thioredoxin induction prevent hyperoxia at 
birth96 
 
Reduced thioredoxin makes a complex with 
ASK1and thereby prevents the downstream 
signaling for apoptosis 32 
 
 
Thioredoxin either activates or inhibits different 
transcription factors are either activated or 
inhibited by Trx 97 
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3.4.1  Thioredoxin role in E.coli Phages 
An extra function of Trx is to act as a structural component of other 
enzyme via complex formation. This is obviously recognized in T7 DNA 
polymerase, where reduced Trx-(SH)2 binds with a highly affinity to the DNA 
polymerase forming a complex  (1 : 1) offering the enzyme a high processivity 
30. Markedly, only the reduced Trx-(SH)2 binds while the oxidized Trx-S2 is 
unable to bind despite being closely related in their 3D structures. A comparable 
structural activity role is presumed for the Trx role in filamentous phage (M13, 
T7 and f1) assembly, although active site mutants were as efficient as Trx in its 
wild status, however, the last had to be reduced firstly by Trx reductase for 
effective functioning in phage assembly 31, and thus creating a significant 
similar situation as the interaction with T7 DNA polymerase.  
 
3.4.2  Thioredoxin role in mammals 
In the same way, the mammalian reduced form of Trx-(SH)2, but not the 
oxidized form of Trx-S2, forms an inhibitory complex with the apoptosis 
pathway; Apoptosis Signaling Kinase 1 (ASK1) 32. Basically, the mammalian 
reduced Trx-(SH)2 offers a redox regulation on apoptosis, where apoptosis 
inhibited under the reduced conditions of the intracellular Trx-(SH)2 , that is to 
say, at the oxidative stress conditions, where apoptosis is activated, the Trx is in 
the oxidized status. Additionally, this situation meets with the perception of the 
pivotal role of oxidative stress in inducing apoptosis.  
Different transcription factors are regulated by the redox activity of Trx. 
Subsequently, this offers Trx a dominant role in the thiol redox regulation of 
critical cell functions by modulation of the expression of specific target genes as 
illustrated in the schematic diagram (Figure 9).  
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Figure 9:  Oxido-reductase regulation of cellular systems 
This Schematic diagram is showing the possible redox levels of regulation and their 
cellular response; growth, differentiation or apoptosis. The oxidoreductase activity is 
controlled by thioredoxin, glutathione or glutaredoxin systems and. The balance between 
oxidants and antioxidants control the functioning of proteins directly and regulate the 
gene expression indirectly32. 
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For instance, Trx is crucial for the oxidoreductase regulation of the transcription factor 
NF-kB 33; a transcription factor that regulates the expression of several inflammatory 
genes. Additionally, Trx has a wide-ranging intracellular antioxidant action, where its up-
regulation defends against oxidative stress conditions 34. Another general function for Trx 
in cell signaling is being an electron donor for the family of thioredoxin peroxiredoxins 
and peroxidases, where there are six members at least in mammalian cells that reduce 
oxidizing agents as Hydrogen peroxide 29. Although both glutathione catalases and 
peroxidases could reduce Hydrogen peroxide, it was verified that the human thioredoxin 
peroxidases (human TPxII) when up regulated in cells, they have showed inhibitory 
effect on apoptosis induction via reducing levels of Hydrogen peroxide. In this manner, 
there is a thioredoxin regulatory step on apoptosis induction, which is upstream the 
apoptosis regulator proteins of the Bcl-2 family 35. Until now, the mechanism of secretion 
of Trx from mammalian cells is unknown, as it is not depending on a signal peptide 36. 
Moreover, the secreted human Trx was found to up regulate the IL-2 receptor with a 
demonstrated activity for the co-cytokine factor from the T-lymphocytes 37. Surprisingly, 
it was recognized that this factor and human Trx are the same protein 38, and thereby it is 
now obviously clear the multi-tasks of the extracellular human Trx. The secretion of Trx 
under oxidative damage and inflammation conditions has been detected in both normal 
and neoplastic cells 36, 39. From the clinical point of view, plasma levels of Trx are 
elevated in different cases of patients; rheumatoid arthritis 40, cardiopulmonary bypass 
operations 41 and in Human immunodeficiency infected cases (HIV/AIDS) 42. Basically, 
extracellular Trx has various pro-inflammatory effects via induction of the cytokines 
release from both monocytes 43 and fibroblasts 40. Additionally, one of the recent 
observed activities of Trx, is being a chemotactic protein, that is to say, it induces the 
migration of T-cells, monocytes and neutrophils with a comparable potency to the 
chemokines e.g. IL-8 44. Mutated residues at the Trx catalytic active motif, which is 
normally denoted by having two vicinal Cysteines and comprise in-between two other 
amino acids (Cys-XX-Cys) to Serines caused a loss in chemotactic activity, proposing an 
obvious demand for the oxidoreductase activity. Furthermore, as being a chemotactic 
protein, the concentration-dependent activity of Trx is a bell-shaped relationship similar 
to other chemotactic agents, with a maximum plasma concentration of 25 ng per ml. The 
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only difference between Trx and other chemokines in being G-protein-independent. Also 
it was found that Trx might inhibit the action of other chemokines 44; thus if Trx levels 
are highly expressed in severe acute inflammations, this could inhibit the cell migration, 
leading to the increase of infection severity. Besides, the truncated Trx (Trx80), which is 
found at the surface of monocytes 45, is highly identical to Eosinophilic Cytotoxicity 
Enhancing Factor (ECEF), which augments the capability of eosinophils to kill the 
Schistosoma mansoni larvae 46, 47. To wrap up, it is obviously clear that the mammalian 
Trx system is a key player that is highly associated with many human diseases as shown 
in Figure 10. 
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Adopted from Thioredoxin and thioredoxin reductase: Current research with special reference to human disease. 
A. Holmgren, J. Lu. Biochemical and Biophysical Research Communications 396, 120–124 (2010). 
 
Figure 10:  Mammalian thioredoxin system and human diseases 
The mammalian Trx system is a key player that is highly associated with many human 
diseases; cancer, cardiovascular, diabetes, neurodegenerative diseases, virus infection, 
rheumatoid arthritis and others.  
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3.4.3  Thioredoxin role in Plants 
Interestingly, plants are characterized by having their unique Trx system, 
where there is a linkage from light to reduction of other disulfide proteins 
through various chloroplast Trxs and ferrodoxin 48. Trxs are implemented in a 
broad spectrum of crucial functions in plants; growth, flowering, photosynthesis 
and germination as well as development of seeds. Furthermore, plants have 
extraordinarily different types of Trxs, where they are composed of six well 
recognized types: Trxs f, Trx m, Trx x, Trx y, Trx h, and Trx o.  Basically, each 
type is located in a different plant cell compartment, where they function in a 
cascade of processes. For the first time, in 2010 it was discovered that Trx 
proteins have the capability to move from one cell to another, representing an 
unusual form of communication between cells in plants.49  
Furthermore, in plants, the seed is considered as the only tissue with a specific 
function for the Trx/NADH system. Actually, the wheat grain is rich in proteins 
comprising disulfide bonds. Glaidens and Glutaenin are the main storage 
proteins that interact with the Trx redox protein, where these proteins become 
more liable to proteolysis as a result of Trx reduction in addition to the redox 
regulation of disulfide inhibitor proteins. Thus, one of the major roles of Trx in 
plants, is being as an early signal in seed germination.50   
4. Metagenomic; The Window for Unexplored Organisms 
Microorganisms are constantly capturing the scientists’ attention due to 
the fact of being the predominant components of the earth’s biota, where they 
occupy various ecosystems and communities; sea and fresh water, soil, air, etc... 
with crucial functions, which make them in turn largely contribute to the 
diversity of genetic material of life 51, 52. Basically, the genomes of the 
microorganisms were estimated to be double to triple the combined genomes of 
animals and plants 53. Additionally, microorganisms are key players with huge 
influence on human and animals’ health, where the number of microbial cells 
inhabiting the human body estimated to be about 100 trillion cells (10 folds the 
human being cells) 54. Thus, this huge number of microbes inhabiting different 
   
 
22 
 
communities is capturing the interest of scientists to reveal their unexplored 
diversity that could lead to understanding and utilizing new metabolic pathways 
or novel proteins. 
4.1 Metagenomics Approach 
The classical way to study different microorganisms was based on the 
traditional lab culture; solid or liquid media. However, this approach did not 
succeed except for 1% of the microorganisms, which means losing 99% of them 
as a result of lacking simulation and mimics of their original environments 52, 55. 
Fortunately, the metagenomic approaches have resolved the biased 
representation of the microorganisms via the direct isolation of the metagenomes 
from their environmental samples for further characterization via cloning 
vectors, construction of metagenomic libraries and then sequencing of the 
genome 52. And based on that, the Metagenomics term refers to analyzing a 
variety of genomes isolated from environmental sample. Metagenomics term has 
different alternatives; environmental genomics, ecogenomics and community 
genomics 52. 
After isolation and processing of the metagenome from its environmental 
samples, three main pathways can be tracked; Firstly, Direct DNA sequencing, 
where the isolated DNA is randomly sequenced yielding huge amounts of 
sequences (about 400 bp read-length) to be subjected to computational analysis 
to have deeper analysis for the genome of  an environmental community. 
Secondly, 16sRNA phylogenetic analysis that could yield comparative genomics 
studies and the taxonomical classification. And finally, the functional screening 
for novel enzymes and proteins’ discovery, or sequence based screening to study 
novel metabolic pathways and genes, where both screenings processed via 
library construction (Figure 11) 55.  
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Figure 11: Metagenomics Pathways 
After extracting the whole genome directly from their environmental samples 
and processing, we can proceed in one of the following pathways; Direct DNA 
sequencing, 16sRNA phylogenetic analysis or library construction (Sequence or 
Functional analysis) 56.  
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Basically, the functional screening is based on testing the clones of the 
metagenomic library on selective media that are enriched with a specific 
substrate, where target clones can grow. On the other hand, the sequence based 
screening comprises designing primers for targeting genes of interest 55. 
Historically, the first time for the term ‘Metagenomics’ to be introduced was in 
1998 by Jo Handelsman and her colleagues, when they isolated  the metagenome 
of soil microorganisms and cloned in E.coli via Bacterial Artificial 
Chromosomes (BACs) 56.  Furthermore, one of the classical phylogenetic studies 
was done on environmental samples extracted from the Sargasso Sea, where the 
whole genome was directly amplified for the entire 16 rRNA genes without 
culturing that leaded to the identification of new group of bacteria; the SAR11 
cluster 57. However, the idea of direct cloning of DNA from environmental 
samples without amplification by PCR was formerly proposed in 1985 by Pace, 
but was applied in 1991, where environmental samples were collected from 
marine picoplankton community and DNA was isolated and cloned in 
bacteriophage lambda 58.  
4.2      Pyrosequencing technology 
Pyrosequencing technology is one of the advancement that supported the 
Metagenomics approaches in exploring the microbial diversity of any 
community. It is one of the Next-Generation Sequencing (NGS) methods that 
have been applied in different metagenomic studies (Schuster, Fitz-Gibbon, 
Biddle, Brenchley & House, 2008; Roesch et al., 2007; Poinar et al., 2006; 
Sogin et al., 2006).  Pyrosequencing was developed in 1996 by Pal Nyren and 
Mostafa Ronaghi in Sweden. Basically, it is a DNA sequencing technique 
(known also as sequencing by synthesis), where it differs from the traditional 
Sanger method (Chain termination reaction by dideoxynucleotides), in that it 
counts on the detection of the release of pyrophosphate during incorporation of 
complementary nucleotides. The pyrosequencing technique tends to amplify the 
small subunit (SSU) rRNA hypervariable region. In conclusion, there are 
various advantages for this method; Firstly, although the generated reads from 
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the pyrosequencing are shorter than that from the Chain Termination 
Sequencing (traditional Sanger sequencing), where the pyrosequencing reads are 
about 400 bp in length, while the Sanger sequencing reads approximately 700 bp 
per read, however the generated pyrosequencing reads are more intensified in 
magnitude for better coverage and representation. Secondly, pyrosequencing 
technique is of lower cost and finally, it generates unbiased results toward the 
predominant species in the community 53 .  
4.2.1      Pyrosequencing protocol 
The pyrosequencing technique relies on synthesizing of the 
complementary strand for a single helix of unknown DNA by integrating a 
single base pair at a time and detecting it after each incorporation. The template 
strand of DNA is immobile, while different solutions of the four possible 
nucleotides (Adenine, Thymine, Cytosine or Guanine) are consecutively added 
and then removed. Light is generated only when the complement nucleotide 
solution fits the first single unpaired base in the DNA template. The 
identification of the sequence of the DNA template has been allowed by the 
sequence of the four nucleotides solutions that generate chemiluminescent 
signals. The pyrosequencing reaction comprises the following; a single stranded 
DNA template incubated with a sequencing primer with DNA polymerase that 
incorporates the proper, complementary deoxynucleoside triphosphates (dNTPs) 
against the DNA template. Consequently, the nucleotides’ incorporation 
generates pyrophosphate (PPi). Additionally, the reaction comprises Adenosine 
triphosphate (ATP) sulfurylase enzyme that converts the released PPi to ATP in 
an equal amount in the presence of Adenosine 5´ phosphosulfate (APS). The 
generated ATP mediates the conversion of luciferin to oxyluciferin that 
produces quantitatively visible light in presence of luciferase enzyme and 
apyrase enzyme that degrades the unincorporated nucleotides. Finally, a camera 
detects the generated light and the received pyrogram is analyzed 59 (Figure 12).  
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Figure 12: Pyrosequencing technology 
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4.3     Construction of Metagenomic Libraries 
The main objective of constructing a metagenomic library is to facilitate 
the access to the isolated metagenome from an environmental sample for 
advanced screening for target genes, biocatalysts, enzymes or any novel 
proteins. Some safety measures should be followed during constructing a 
metagenomic library; ensure that the isolated metagenome is well representing 
the community of the environmental sample so as to avoid any biased 
representation, the DNA should be intact and not sheared to avoid developing of 
chimeric products among the smaller fragments of DNA, contamination should 
be avoided, and finally, in order to prevent any interference with further 
downstream processes as PCR, the metagenome should be clean and free from 
inhibitors 52, 60. To isolate the metagenome from the collected samples via cell 
lysis, there are two main methods; chemical and physical. The physical method 
comprises freezing and thawing for the samples several times, followed by 
sonication, but these steps could cause DNA shearing. On the other hand, the 
chemical methods that lysis the cells via using SDS is characterized by being 
much gentler than the traditional physical methods. Thus, a mixed recipe of both 
methods can be used as per the nature of the sample, where the metagenome was 
isolated from 52. 
The type of the vector that will be used in constructing the library will be 
decided as per the objective of the study. For instance, if the aim of the study is 
to characterize single genes, thus we can go for small insert library, where the 
used cloning vectors are plasmids (inserts size less than 10 kb). On the contrary, 
if the purpose of the study is to characterize the whole operons or genes’ 
clusters, we have to go for large insert library, where the used cloning vectors 
could be BACs (insert size range 100-200 kb), or fosmids (insert size range 25-
40 kb) or cosmids (insert size 25-35 kb) 61.  Regarding the surrogate host, the 
most convenient and well established used host is the E. coli for various 
advantages; its ease of transformation, high transformation efficiency and its 
exemplified genetics 61.  Moreover, for the same DNA amount, the number of 
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the clones generated from the small insert library are much higher than that of 
the large insert library (about 10 folds), which allows the efficient screening of 
all expressed genes, especially those of low levels of expression 61. In the 
following section, we will discuss the screening approaches. 
 
4.3.1 Sequence based approach 
Usually this approach is followed for phylogenetic analysis, where 
primers are designed as per the conserved regions or domains of the target 
protein or gene. PCR is then performed for screening the library and 
consequently, the whole clone is sequenced to identify the whole gene sequence 
52. One of the privileges of the sequence based approach over the functional 
based approach that it does not depend on the expression of the cloned gene in 
its host (E. coli); while the functional based approach is depending on the gene 
expression in the surrogate host 52. 
 
4.3.2 Functional based approach   
Fundamentally, the functional screening is based on examining the 
clones of the metagenomic library on selective or indicator media that are 
enriched with a specific substrate, where target clones can grow demonstrating a 
color change or halo zones around target colonies 61. The main advantage of the 
functional screening over the sequence screening that it relies on the gene 
functioning away from its sequence, which in turn open the window of 
opportunities for discovering novel proteins; enzymes, biocatalysts, receptors or 
membrane transporters,  that might share the same functions with other 
identified proteins but with other unique gene sequence 62. However, the main 
drawback in the functional screening is the mandatory heterologous gene 
expression of the cloned gene in the surrogate host; which is mostly E. coli 4, 52, 
61. Though E. coli is the classical surrogate host used in the functional based 
screening, the risk of failure of heterologous gene expression is valid with high 
percentage. An example of such failure was demonstrated in a metagenomic 
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study on the metagenome of 32 prokaryotes, where only 40% of the genes were 
heterologousely expressed in E. coli, while 60% of the genes were missed 61. 
Besides, it could be possible that the percentage of the successful heterologous 
gene expression to be varied and could be lessen than 40 % as per the nature of 
the environment where the samples have been collected from, for instance, the 
extreme environments in terms of temperature, salinity, heavy metals, lack of 
nutrients, etc. By analyzing the reasons behind the failure of heterologous gene 
expression in E.coli, we have to pay attention that the isolated metagenomes 
from their complex communities are expected to have unusual and unique 
regulatory factors that are mandatory for the appropriate transcription and 
translation, while the E.coli could lack them. An example for codon usage in E. 
coli is the start codon, which is AUG; the most common start codon (91%), 
versus other codons that could be preferred as start codons in other organisms or 
environments 4. Other reasons that could account for weak or failure of 
heterologous gene expression are: toxicity of some genes upon expression 
towards the surrogate host or lack of the required chaperones for folding protein, 
yielding misfolded proteins 52. 
5. Adaptation of Organisms in extreme environment 
Various organisms are inhabiting extreme environments; halophiles, thermophiles, 
acidophiles, alkalophiles, etc..., where they produce unique proteins of exceptional 
properties and characteristics so as to accommodate with the surrounding environment 63. 
In our study, the collected samples were from a thermohalophilic environment; LCL of 
Atlantis II Deep brine pool in the Red Sea, thus it is expected that our retrieved 
thioredoixn is of thermophilic and halophilic nature. 
5.1 Thermophilic adaptation  
Conferring to the optimal functional activity at a wide range of 
temperatures, bacterial proteins can be categorized into 4 groups; 
hyperthermophiles (active at more than 80 oC), thermophiles (active from 45 oC 
to 80 oC), mesophiles (active from 15 oC to 45 oC) and finally psychrophiles that 
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are active from 5 oC to 10 oC 64. Basically, the first two groups; 
hyperthermophilic and thermophilic, can withstand and properly function at 
extremely harsh circumstances; high metal content, low nutrients, high salinity, 
temperature, etc… 64. The main features of the thermostable proteins are the 
covalent bonds, extra hydrogen bonds, the rich hydrophobic core and the Van 
der Waals interactions65, 66, 67.  
5.1.1 Forces influencing protein’s stability towards Thermo-Halophilicity 
There are a variety of forces and bonds that influence the stability of 
proteins. Basically, there is a balance between those forces that maintain the 
native structure of protein versus other forces that could oppose protein’s 
stability 68.  The main contributing force for the protein’s stability is the covalent 
bond, where common electrons can be shared by two molecules. Thioredoxin’s 
active site (Cys-X-X-Cys) is characterized by having two vicinal cysteines, 
where cysteine amino acid tends to perform disulfide bridge (S-S) upon reducing 
other amino acids using its sulfhydryl group (SH). The performed disulfide 
bridge is a strong covalent bond. Thus, the thioredoxin’s active site is playing a 
crucial dual role; maintenance of thioredoxin structural folding as well as the 
catalytic antioxidant activity of the protein 69, 70. On the other hand, although 
Van der Waals forces, electrostatic and hydrophobic interactions do not share 
electrons among molecules and characterized by being much weaker than 
covalent bond, they have a role in the conformational stability of the proteins 69, 
70.  
5.1.2 Role of Salt bridges in protein stabilization 
The salt bridge bond is a type of electrostatic interaction, where it is 
formed between ionized residues of opposite charges. That is to say, salt bridges 
could be in favor of protein’s stability or not for two main reasons; firstly, the 
performed salt bridge could be of attractive or repulsive nature. Secondly, to 
perform the electrostatic interaction, re-organization of the conformational 
structure of protein is mandatory, which in turn could affect protein’s stability. 
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Consequently, salt bridges play different roles in proteins; molecular 
recognitions, key and lock feature at enzymatic binding sites or protein’s 
stability 68. The locations of salt bridges within the protein structure are variant; 
(a) on protein surface, (b) fully buried within protein structure or (c) partially 
buried (Figure 13). Additionally, salt bridges are pH dependent, thus, the 
presence of salt bridges in proteins is highly influencing the thermo-halophilicity 
nature of proteins. Finally, it is well established that thermo-halophilic proteins 
are characterized by being highly thermo-halophilic stable due to their richness in 
salt bridges within their structures 68.  
 
Captured from Bosshard, H.R., D.N. Marti, and I. Jelesarov, Protein stabilization by salt bridges: concepts, experimental   
approaches and clarification of some misunderstandings. J Mol Recognit, 17(1): 1-16 (2004) 
Figure 13: Different locations of salt bridges within protein structure 68 
The figure is showing the probable locations of salt bridges within a protein moiety, where 
the heavy line is demonstrating a polypeptide chain, while the following points are: 
(a) and (b) are representing salt bridges on the surface of protein.  
(c) is demonstrating fully buried location in the depth of protein. 
(d) is demonstrating partially buried location in the depth of protein 
(e) Other charges affecting salt bridges. 
(f) Complex salt bridge. 
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5.2 Halophilic adaptations 
 Halophilic organisms can exceptionally tolerate harsh salinity conditions, where 
they can grow in media comprising salts from 0.5 M till 5 M as per their classification; 
halo-tolerant, moderate halophiles, borderline extreme halophiles and extreme halophiles 
71. Furthermore, halophiles can be defined as microorganisms that are optimally grow at 
0.85 M NaCl, with tolerability until 1.7 M NaCl. Basically, the osmotic balance within 
the halophilic microorganisms and the surrounding environment is maintained via one of 
two main tactics; (a) Salt out tactic: where osmotic solutes of organic nature as ectoine, 
L-proline and glycerol are accumulated inside the cytoplasm of halophiles, allowing the 
cells to flux out salts, without interfering with the activity of cellular proteins.  (b) Salt in 
tactic: where high molar concentration of ions; Chloride and Potassium are accumulated 
inside the cytoplasm of halophiles, allowing the cellular machinery to be adapted to high 
concentrations of salts while being active and functioning 72, 73 .  
6. Thioredoxin Therapeutic Applications 
Thioredoxin is a small monomeric redox protein (12 KDa) that 
ubiquitously exists in human body. It is considered as one of the defensive 
proteins, which is induced in response to numerous oxidative stress conditions. 
Adding to its anti-oxidative activity via dithiol-disulfide exchange, thioredoxin 
has anti-inflammatory and anti-apoptotic activities. The overexpression of 
thioredoxin in different animal models has been demonstrated to be a key player 
in the inflammatory disorders and oxidative disorders as well. Interestingly, 
administration of recombinant thioredoxin has shown anti-inflammatory 
efficacy in severe acute lung diseases. Furthermore, thioredoxin has shown anti-
chemotactic activities for neutrophils as well as inhibitory actions against 
macrophage migration inhibitory factor (MIF). To sum up, administration of 
recombinant thioredoxin could have a wide range of potential therapeutic 
applications in the medical field that should be examined in various animal 
models 74. 
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7. Study Objectives and Experimental Plan 
 
The main objective of this study was to identify a novel TrxATII from 
the LCL of Atlantis II Deep brine pool in the Red Sea. The proper primers have 
been designed as per the conserved domains of Trx and the full gene was 
retrieved by performing PCR directly on the 1x metagenome of the LCL, 
followed by gene sequencing. 
 
The second objective was the TrxATII heterologous protein expression after 
being cloned in the proper expression vector and transformed into the proper 
surrogate host (E.coli BL21, (DE3)), where the expressed protein was 
characterized by being His-tagged to allow the protein purification. 
Additionally, the induction phase of the TrxATII was done by using IPTG, 
where the expressed TrxATII appeared at its proper size on the SDS-PAGE gel. 
 
The third objective was the purification of TrxATII. The purification procedures  
was done using Nickel affinity chromatography, where the His-tagged TrxATII 
was bound to the Ni+ ions, and subsequently, eluted with the proper elution 
buffer that comprises imidazole of high concentration.  
 
The fourth objective was to assess the activity of the purified thioredoxin. 
Basically, we have examined the TrxATII antioxidant activity via different 
assays; Oxidative stress induction assay on HepG2 cell lines (MTT assay), 
DTNB reduction assay and Insulin reduction assay.  
 
The final objective was to characterize the thermal stability and halotolerance of 
the purified thioredoxin. To achieve this goal, TrxATII was incubated for a 
definite time intervals at various salt concentrations and temperatures, followed 
by measuring the residual activity of the protein. Figure 14 is showing 
schematic representation for the experimental plan. 
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Figure 14: Schematic representation for the experimental plan 
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Chapter 2: Materials and Methods 
1. LCL Samples  
All samples that have been used along the study were collected during the 
expedition of KAUST (King Abdullah University for Science and Technology) at the 
Red Sea in spring 2010. Moreover, the site where the samples have been collected was 
the lower convective layer of the Atlantis II deep brine pool; latitudes 21° 13’N and 21° 
30’N and longitudes 37° 58’E and 38° 9’E 8. The total volume of the samples was about 
100 liters. Subsequently, the samples were serially filtered via 3 µm, 0.8 µm and 0.1 µm 
filters. The aim of the serial filtration is to fractionate the prokaryotic community. 
 
2. Amplification of LCL genome 
The whole genome of the Lower Convective Layer (LCL) of the Atlantis II brine 
pool of Red Sea was amplified by Mr. Amged Ouf using REPLI-g Mini Kit 
(Cat.No.150023, QIAGEN). Basically, the REPLI-g Mini Kit generates a high yield of 
DNA based on Multiple Displacement Amplification (MDA) technology, where the Phi 
29 polymerase (high-fidelity enzyme) is used to amplify complex genome in combination 
with a denaturation step of gentle alkaline condition to allow a uniform amplification of 
genomic loci. The kit yields about 10 µg DNA per 50 µl reaction that remains stable in a 
long term storage conditions. Interestingly, the easy set-up of the reaction and the 
convenient handling time (about 15 minutes) makes the REPLI-g Mini Kit a reliable 
method to use in amplifying whole genome in precious samples 75. 
 
2.1     Whole genome amplification Concept 
The Multiple Displacement Amplification (MDA) technology is also known as 
isothermal genome amplification. The MDA technology is based on binding random 
hexamers to denatured fragments of DNA. Using the high-fidelity enzyme Phi29 
polymerase at constant temperature, the strand displacement synthesis occurs, where 
multiple priming events take place on every displaced strand, which serves as a template 
that allows the generation of high outcomes and consistent yield of amplified DNA as 
shown in Figure 15.  
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Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomic- 
dna/repli-g-mini-kit#productdetails 
 
Figure 15: Consistent DNA yields using REPLI-g Mini Kit 
Different starting materials comprising genomic DNA have been amplified using REPLI-
g Mini Kit, where the yields are ranging from 8 to10 µg. 
The high-fidelity enzyme Phi 29 is a DNA polymerase - phage derived enzyme -, with 
proofreading activity (3'→5' prime exonuclease activity).  The Phi29 polymerase is 
characterized by higher fidelity than Thermus aquaticus (Taq) DNA polymerase (about 
1000-fold) as shown in Figure 16. Additionally, the REPLI-g Mini Kit is supported by a 
unique buffer system that prevents slippage or stopping of polymerase along 
amplification procedure via resolving any secondary structures as hairpin loops 75.  
 
 
Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomic- 
dna/repli-g-mini-kit#productdetails 
 
Figure 16: LCL genomic amplification by Phi29 polymerase 
[A] Taq polymerase may stop synthesis or detach from the DNA template upon coming 
across a secondary DNA structure, thus could yield inappropriate DNA amplification and 
short fragments [B] Upon coming across a secondary DNA structure, the Phi29 
polymerase displaces the structure as shown allowing high integrity for the amplified 
genome. 
   
 
37 
 
2.2    DNA Denaturation 
To proceed in the enzymatic amplification of the LCL genome, gentle alkaline 
incubation is maintained instead of ordinary harsh conditions; high temperatures 
incubation or high alkaline incubation. Subsequently, the gentle alkaline incubation 
allows the uniform denaturation of LCL genome with a minimal DNA fragmentation and 
the final DNA yield is characterized by high integrity and maximized length of the 
amplified fragments, which in turn allows the genomic loci and sequences to be 
represented uniformly without negative results or false positive. The effect of heat 
denaturation versus alkaline denaturation for genomic DNA in terms of Ct values 
(threshold cycle) (Figure 17). Basically, the Ct value (threshold cycle) is a relative 
measure in the PCR reaction for the concentration of target DNA. The Ct value increases 
with a decreasing amount of template. Thus, the lower the Ct values the better 
representation of loci 75. 
 
Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample 
technologies/genomic-dna/repli-g-mini-kit#productdetails 
 
Figure 17: Heat effect versus alkaline denaturation effect on loci representation 
10 ng of genomic DNA samples were denatured at 95°C versus gentle alkaline denaturation 
by REPLI-g Kit. Later on, after amplification, the CT values (threshold cycle) for 2 loci were 
calculated and compared between the 2 conditions. It is clear that the CT values of the 
amplified loci by the REPLI-g Kit is much lower than that of heat denaturation method, which 
indicates better representation for the locus with no loss of sequences at these loci.  
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2.3  Amplification Procedures 
The LCL genomic sample is lysed by the addition of the lysis buffer, which has a 
dual role; Sample lysis and DNA denaturation via its one minute gentle alkaline 
incubation. Consequently, the denaturation step is stopped by   adding the neutralizing 
buffer, followed by addition of the  master mix (including REPLI-g Mini DNA 
Polymerase), where the multiple displacement amplification reaction proceeds at 30°C 
overnight (at least 10-15 hours). The procedure of DNA amplification is illustrated in 
Figure 18. Finally, the whole amplified genome can be stored –20°C for a long-term 
period stable and consistent 75. 
 
 
 
Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomic-
dna/repli-g-mini-kit#productdetails 
 
Figure 18: Procedure of the whole genome amplification of the LCL 
genome by REPLI-g Mini kit  
Amplification of the LCL genome comprises 3 main steps: 
1- 10 ng of purified LCL genome undergoes gentle alkaline denaturation. 
2- Sample neutralization. 
3- Incubation at 30°C with REPLI-g master mix. 
1 
2 
3 
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3. Retrieving TrxATII gene 
3.1     DNA isolation  
TrxATII gene was retrieved directly from the metagenome of the lower convective 
layer of the Atlantis II deep brine pool (1x LCL) via PCR reaction. As per the conserved 
regions of thioredoxin gene, we have designed the primers to retrieve the full gene as 
follow; forward primer (TrxF) 5’- GGA TCC GTG CAA TCT GAA AGT CGA GAG 
TC-3’ and the reverse primer (TrxR) 5’- AAG CTT TTA TCC ATG AGT GCG TGG 
ACT AA -3’. Furthermore, the PCR conditions were as follow: initial denaturation at 
95oC for 5 minutes, 35 cycles (95oC for 30 seconds, 63oC for 30 seconds and 72oC for 1 
minute) and a final elongation stage at 72oC for 7 minutes. The used thermo-stable DNA 
polymerase was DreamTaq DNA Polymerase (# EP0701, Thermo SCIENTIFIC). 
Additionally, the used PCR thermal cycler was Veriti 96 wells (Model No.9902, Applied 
Biosystems). 
3.2 Agarose Gel Electrophoresis 
Agarose gel electrophoresis is a well-known method in molecular biology, which 
is used to separate a mixed population of DNA in the agarose matrix. By applying 
electric field, the negatively charged biomolecules are separated based on their size 
through the agarose matrix, where the small sized DNA fragments migrated faster 
downwards the agarose gel 76. We have used; 0.8% agarose, the running buffer was 1x 
TBE (Tris/Borate/EDTA) for its good conductivity and less heat productivity, reference 
molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus DNA Ladder 75 to 
20,000 bp (Ferementas Cat. No.SM1331). We have run the 0.8% agarose gel in Bio Rad 
electrophoresis chamber (Mini Sub® Cell GT) and finally the separated bands of DNA 
fragments was viewed using Image Quant 300 (Serial No. 300-06-00130, General 
Electric). 
3.3 Excision and Extraction of TrxATII gene from agarose gel 
           At the proper size of TrxATII gene (~540 bp), we have excised the DNA fragment 
from the 0.8% agarose gel with a clean, sharp scalpel. Consequently, to extract and purify 
the DNA fragment, we have used QIAquick Gel Extraction Kit (Cat. No. 28704) supplied 
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by Qiagen, where we have followed its protocol. Finally, we have the purified DNA 
fragment in a 30 μl Buffer (10 mM Tris Cl, pH 8.5). 
 
4. Recombinant TrxATII Clones 
4.1 Cloning and Transformation of TrxATII gene 
           TrxATII gene was then cloned into a high copy number vector. The used plasmid 
was pGEM®-T Easy (Cat. No. A1360, Promega).  Basically, pGEM®-T Easy is a 
linearized vector with T-overhangs at the insertion site that significantly improve the 
efficiency of ligation of PCR product with a compatible overhanging. Furthermore, 
ligation procedure was done according to the manufacturer’s instructions. Subsequently, 
2 ul of the ligation reaction was used to transform electrocompetent E. coli TOP10 cells 
using MicroPulser™ Electroporation Apparatus (Bio-Rad) as per the instructions of 
manufacturer. The tube containing transformed E. coli TOP10 cells and ligation reaction 
was incubated with 950μl room-temperature LB broth / Ampicillin (100μg/ml) for 1.5 
hours at 37°C with shaking (200 rpm). Finally, 100μl of each transformation culture were 
plated on LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml) agar plates 
and incubated overnight at 37°C. The features of the pGEM®-T Easy vector are shown in 
Figure 19. 
 
Figure 19:  pGEM®-T Vector Map 
Captured from the manual of pGEM®-T and pGEM®-T Easy Vector Systems  
(Part#TM 042, www.promega.com) 
   
 
41 
 
4.2 Screening of Recombinant Transformants  
            The pGEM®-T Easy vector comprises a multi-cloning site within the alpha 
peptide coding sequence of β-galactosidase enzyme and flanked by T7 and SP6 RNA 
polymerase promoters. Successful cloning of TrxATII gene into the pGEM®-T Easy 
vector will interrupt the coding sequence of β-galactosidase enzyme and thus, successful 
recombinant clones can be recognized by screening of colored colonies on indicator 
plates (Blue/White screening of recombinants). The white colonies will comprise TrxATII 
insert at the proper cloning region, while the blue colonies might comprise the TrxATII 
gene but cloned in-frame with the lacZ gene or might not comprise the insert at all. 
Twenty white colonies were picked up from indicator plates for gene sequencing. 
 
5. TrxATII gene Sequencing 
5.1      Plasmid Extraction 
To proceed in gene sequencing, firstly we need to extract the pGEM®-T Easy 
plasmid comprising the TrxATII gene insert from the recombinant E. coli TOP10 cells 
(White colonies). Out of the indicator plates, twenty white colonies were picked up with 
autoclaved picks, where each picked colony sub-cultured in a separate falcon tube 
containing LB broth/Ampicillin (100μg/ml) overnight at 37°C with shaking (200 rpm).  
For plasmid extraction, we have used the PureYield™ Plasmid Miniprep System 
(Cat.No.A1223, Promega), which is designed to extract highly pure plasmid DNA. We 
have followed the manufacturer’s protocol in isolating the twenty plasmids. Finally, we 
have 30 μl of each plasmid in a separate eppendorf tube and stored at -20°C, where the 
plasmids stored in 10mM Tris-HCl (pH 8.5) and 0.1mM EDTA buffer. To determine the 
concentration of the extracted plasmids, we ran them on 0.8% agarose gel 
electrophoresis. 
5.2 Chain Termination Sequencing 
To carry out Sanger sequencing (Chain Termination Sequencing), Mr. Amged ouf 
has used Applied Biosystems 3730xl DNA Analyzer machine using the BigDye® 
Terminator v3.1 Cycle Sequencing Kit. For each plasmid, two reactions were performed, 
where each reaction contains: Big dye terminator, 5X Sequencing Buffer, primer 
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(forward or reverse), DNA template and the volume was completed using water. The 
used primers were thioredoxin forward (TrxF) and thioredoxin reverse (TrxR). 
Thermocycler conditions were initial denaturation step at 96oC for 1 minute, 25 cycles 
(denaturation at 96oC for 10 seconds, annealing at 63oC for 5 seconds and extension at 
60oC for 4 minutes). TrxATII gene sample to be sequenced was purified using the Edge-
Biosystem Columns, dried and loaded into the 96 well optical plate.  
 
6. Computational Analysis  
6.1      TrxATII sequence and alignment analysis 
After sequencing the positive TrxATII clones by Applied Biosystems 3730xl 
DNA Analyzer machine, the generated sequence was BLASTed against non-redundant 
(nr) protein databases using Basic Local Alignment Search Tool (BLASTP) provided by 
the National Center for Biotechnology Information (NCBI). Furthermore, the generated 
sequence was aligned against the first hit; Trx Prochlorococcus  marinus  (accession 
number WP_002807427.1), using ClustalW version 2.1 77,78. Moreover, a multiple 
alignment was generated for the TrxATII against other members of the Trx super family 
using ClustalW version 2.1 to detect the conserved active catalytic site. 
 
6.2 3D modeling of TrxATII versus Trx of Prochlorococcus  marinus 
Using the PyMOL Molecular Graphics System (Version 1.3 Schrödinger, LLC), 
we have made a 3D modeling for the TrxATII versus Trx of Prochlorococcus  marinus. 
 
6.3 Construction of Phylogenetic tree  
A Phylogenetic tree for the TrxATII was constructed using CLUSTALW version 
2.1 77,78 . The generated tree is Neighbour-joining tree including the sequences most 
similar to the TrxATII sequence. 
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7. Expression of TrxATII 
7.1     Cloning of TrxATII gene in Expression Vector 
TrxATII gene was cloned into a high level expression vector with a TA cloning 
site for efficient cloning. The used expression system was the Champion™ pET SUMO 
Protein Expression System (Catalog No.K300-01) supplied by invitrogen™. Basically, 
the Champion™ pET SUMO Protein Expression System utilizes a small ubiquitin-like 
modifier (SUMO; Smt3 protein of the Saccharomyces cerevisiae) that facilitates 
expression, purification, and generation of native heterologous proteins in the surrogate 
host; E. coli. Additionally, the pET SUMO vector takes the privilege of the bacteriophage 
T7 RNA polymerase that allows high-level, IPTG-inducible expression of heterologous 
genes in E. coli under the T7 lac promoter, plus solubility enhancement of partially 
insoluble proteins. Moreover, the presence of the N-terminal polyhistidine (6xHis) tag in 
the pET SUMO expression vector allows purification of the recombinant TrxATII protein 
against metal-chelating resin (Ni-NTA agarose resin, Cat.No. R901-15, Invitrogen™), 
where the Ni-NTA resin has high affinity and selectivity for 6xHis-tagged recombinant 
fusion proteins. The features of the pET SUMO vector are shown in Figure 20. 
Following the manufacturer’s protocol, we have cloned TrxATII gene in pET SUMO 
vector after performing PCR with the previously mentioned conditions. The ligation 
reaction was incubated at room temperature for 30 minutes then stored at   -20°C. 
 
Figure 20: pET SUMO® Vector Map 
Captured from the manual of pET SUMO Vector (Cat.No.300-01, invitrogen™)  
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7.2     Transformation of Expression Vector into E. coli  
The BL21 (DE3) E. coli strain (supplied by invitrogen™) is precisely designed 
for expression of heterologous genes under the T7 promoter. Following the 
manufacturer’s transformation instructions, 2 ul of the ligation reaction was used to 
transform the chemically competent BL21 (DE3) E. coli cells. After that, the tube 
containing transformed E. coli cells and ligation reaction was incubated with 250 μl 
room-temperature LB broth/kanamycin (50 μg/ml) for 1.5 hours at 37°C with shaking 
(200 rpm). Finally, 100μl of each transformation culture were streaked on LB and 
kanamycin (50 μg/ml) agar plates to be incubated overnight at 37°C. 
7.3     Analyzing Transformants 
To analyze transformants, we performed PCR reaction as the previously 
mentioned conditions for each transformation culture using the TrxF (Thioredoxin 
forward primer) and TrxR (Thioredoxin reverse primer). The generated PCR product was 
run on 0.8% agarose gel electrophoresis to confirm the positive transformants. 
7.4     IPTG-inducible Expression of TrxATII 
Transformant BL21(DE3)  E. coli cells comprising the pET SUMO vector with 
TrxATII gene insert were sub-cultured in LB broth / kanamycin (50 μg/ml) with shaking 
(200 rpm) and incubated overnight at 37°C. In the following day, in a clean autoclaved 
500 ml. flask, 1 ml. of the overnight culture were added to 100 ml. of LB 
broth/kanamycin (50 μg/ml) and incubated at 37°C with 200 rpm shaking for about 3 
hours until reaching optical density (OD) from 0.4 to 0.6 at wavelength (ʎ) 600 nm, 
where we measured OD using Ultrospec 3100 pro (UV/visible spectrophotometer, 
Amersham Biosciences). After reaching the desired optical density, we started the 
induction phase using IPTG (isopropyl β-D-thiogalactoside) of final concentration 0.1 
mM, followed by incubation at 37°C with shaking at 200 rpm overnight.  By the 
following day, we have isolated the E. coli cell pellets from supernatant via 
centrifugation for 10 minutes at 5000 rpm using Allegra® X-12R centrifuge 
(BECKMAN COULTER, USA). Moreover, the E. coli cell pellets were collected and 
dissolved in 1ml. of the binding buffer (250 mM NaH2PO4 / 2.5 M NaCl) that will be 
used later on in the purification of the expressed TrxATII protein. To extract the cell’s 
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proteins out of the cell pellets, we applied 100 watts of sonication power for effective 
processing using Branson Sonifier 150 machine (Model No.S-150D, USA), where we 
freezed and thawed the cell pellets for three successive times in -80°C and 42°C 
respectively and finally we applied sonication for 5 minutes (15 seconds on and 15 
seconds off). To collect the total expressed proteins, we centrifuged the sonicated cell 
pellets at 13,000 rpm for 10 minutes, where we separated the supernatant comprising the 
whole cell’s proteins. 
7.5     SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE is a well-known molecular biology technique that used to separate 
proteins from a pool of different proteins based on their molecular weight through the 
polyacrylamide sieve like matrix. The small sized proteins run faster than larger sized 
proteins, where each protein represented by a clear separate band. In this technique, 
proteins reacted with SDS (Sodium dodecylsulfate) forming negative charge complexes, 
where the amount of SDS that bounds to each protein is approximately proportional to its 
size 79. We have analyzed the E. coli proteins on 17% SDS gel. To prepare the 17% 
resolving gel, we have mixed; 3.75 ml 30% Acrylamide/Bisacrylamide (37.5:1), 3 ml 
Tris-HCl (pH 8.6), 40 ul 20% SDS and 1.2 ml water, then just before casting the gel, we 
added 48 ul 10% Ammonium per Sulfate (APS) and 12 ul of Tetramethylethylenediamine 
(TEMED). To prepare the stacking gel, we have mixed 820 ul of 30% 
Acrylamide/Bisacrylamide (37.5:1), 0.5 ml Tris-HCl (pH 6.9), 20 ul 20% SDS and 2.7 ml 
water, then just before casting the gel, we added 20 ul 10% Ammonium per Sulfate 
(APS) and 10 ul of Tetramethylethylenediamine (TEMED). The loading dye recipe was 
1% SDS, 10% glycerol, 10 mM Tris-Cl (pH 6.8), 1 mM ethylene diamine tetraacetic acid 
(EDTA) and 0.05 mgl/ml bromophenol blue. Then, for every 950 ul loading dye, we 
added 50 ul of 2-mercaptoethanol as a reducing agent. To load the protein samples, we 
added 6 ul of cell’s proteins to 24 ul of loading dye and allow denaturation at 90°C with 
vigorous shaking for 5 minutes and finally, we loaded 20 ul of denatured protein per SDS 
gel’s well. Furthermore, different samples were collected before and after induction.   
The used electrophoresis apparatus was Bio-Rad Mini-PROTEAN Tetra Cell, where we 
ran the cell’s proteins till before the end of the gel. For gel staining viewing the protein’s 
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band, we used Commassie Brilliant R-250. The used reference molecular weight ladder 
was ProSieve®Color Protein Markers (Cat. No.50550, Lonza). 
 
8. Purification of TrxATII 
The pET SUMO expression vector is characterized by having N-terminal 
polyhistidine (6xHis) tag that allows purification of recombinant TrxATII against metal-
chelating resin (Ni-NTA agarose resin, Cat.No.R901-15, Invitrogen™), where the Ni-
NTA resin has high affinity and selectivity for 6xHis-tagged recombinant fused proteins. 
Following the instructions of the manufacturer, we purified the E. coli whole proteins 
under the native conditions, where we loaded the whole proteins on Ni-NTA agarose 
resin after column’s equilibration with binding buffer (250 mM NaH2PO4 / 2.5 M NaCl) 
for 3 successive times. Then, the column was gently agitated for 60 minutes to keep 
the loaded proteins suspended within the resin to allow efficient binding. After resin 
settlement by gravity, the resin washed with 8 ml native wash buffer (20 mM 
imidazole/250 mM NaH2PO4 / 2.5 M NaCl) for 3 successive times to allow elution of 
whole E. coli proteins except TrxATII protein that fused to polyhistidine (6xHis) tag. 
Finally, TrxATII protein was eluted into 0.5 ml fractions using native elution buffer 
(250 mM imidazole/250 mM NaH2PO4 / 2.5 M NaCl), via competition against 
imidazole. Samples of purified TrxATII were taken for SDS-PAGE electrophoresis 
analysis. 
 
9. Dialysis of TrxATII Fractions 
The presence of imidazole within the eluted fractions of TrxATII might affect the 
protein’s activity, thus we removed the imidazole via dialysis. We collected all eluted 
TrxATII fraction in a dialysis bag, then we allowed imidazole exchange against 1x PBS 
(Phosphate Buffered Saline) via gentle vortex at +4°C overnight. For preparing 10x PBS, 
we mixed 80 gm NaCl, 2 gm KCl, 14.4 gm Na2HPO4 and 2.4 gm KH2 PO4 in 1 liter 
autoclaved water (pH 7.4). 
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10. Quantification of TrxATII Fractions  
After dialysis, we quantified the amount of TrxATII protein using the Thermo 
Scientific Pierce BCA Protein Assay (Cat.No.23225, Thermo SCIENTIFIC). Basically, 
this assay combines the reduction of Cu+2 to Cu+1 by protein in a basic medium with the 
highly sensitive and selective colorimetric detection of the cuprous cation (Cu+1) using a 
reagent comprising bicinchoninic acid (BCA). Accordingly, a purple-colored product is 
formed as a result of chelation of two molecules of BCA with one cuprous ion. 
Interestingly, this purple-colored product exhibits a significant absorbance at 540-590 nm 
that shows a liner relationship by increasing the protein concentration over a working 
range from 20μg/ml to 2000μg/ml. Moreover, we followed the manufacturer’s protocol to 
determine unknown concentrations of TrxATII. The used reference protein standard was 
bovine serum albumin (BSA). Finally, we plotted a standard curve.  
11. Redox Activity and Characterization of TrxATII 
11.1 Insulin reduction activity assay  
Thioredoxins are antioxidant proteins that assist the reduction of other proteins 
via the exchange of cysteine thiol disulfide. Thus, the standard way to assess the redox 
activity of Trx protein is the reduction assays. Basically, the insulin molecule consists of 
two polypeptide chains; A and B chains, where they are linked together via disulfide 
bridge 80 as shown in Figure 21.  
 
 
http://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?id=7043&type=display 
Figure 21: Structure of Human Insulin 
Human insulin is composed of two subunit chains A and B. Chain A comprises 21 amino 
acids, while chain B comprises 30 amino acids. The two chains are bounded by two 
sulphide bridges enclosed in red circles. Upon reduction, the two chains separated 
forming thiol groups (SH SH) and insulin aggregates formed, which can be measured 
spectrophotomerically at 650 nm 78.   
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The insulin reduction assay is based on the reduction of insulin chain, where its disulfide 
bridge broken down (S-S to SH SH) in the presence of the active reduced form of 
thioredoxin that results in the formation of insulin aggregates, which can be measured 
spectrophotomerically at 650 nm. Moreover, the reduction initiation occurred in the 
presence of Dithiothreitol (DTT). We have performed the assay in 1 ml reaction as 
follow; In a clean cuvette, 2mM Ethylenediaminetetraacetic acid (EDTA), 100mM 
KH2PO4, 0.7mg/ml insulin (Human insulin, Cat.No.I0908, Sigma, Denmark), 4μM 
TrxATII, 0.33mM Dithiothreitol (DTT), and completed the final volume with water to 1 
ml. 
 
 11.1.1 Thermo-stability 
The redox activity of the TrxATII examined in the insulin reduction assay was 
assayed after incubation of TrxATII at different temperatures (25-80oC). 
 
11.1.2 Halophilicity 
The redox activity of the TrxATII examined in the insulin reduction assay was 
assayed at different NaCl concentrations (0-4 M). 
 
11.2 In Vitro assay of TrxATII antioxidant activity 
11.2.1 Cell Culture 
Another way to examine the antioxidant activity of thioredoxin protein was to 
induce oxidative stress conditions on mammalian cell line and then asses the role of 
thioredoxin as an antioxidant. In this assay, we induced oxidative stress conditions on 
HepG2; hepatic cancer cell line, where we obtained the cell line from the Holding 
Company for Biological Products & Vaccines (VACSERA) in Egypt. To allow the growth 
of HepG2 cancer cell line, we have used RPMI 1640 medium (Roswell Park Memorial 
Institute) with L-Glutamine and 25 mM Hepes (Cat.No.BE12-115F, Lonza, USA) 
containing 10% Fetal Bovine Serum (FBS) (Cat.No.DE14-701F, Lonza, USA) and 5% 
penicillin-streptomycin mixture (10,000 units Potassium Penicillin and 10,000 μg 
Streptomycin Sulfate per ml) (Cat.No.17-602E, Lonza, USA), where the cell line was 
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incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO2. The HepG2 cell 
line reached a confluence stage after 24 hours incubation. Moreover, along the study, we 
performed 15 passaging (from 35 to 50). To allow the growth of the cell line, passaging 
was done from T-25 culture flask (25 cm2) to T-75 culture flask (75 cm2), where we used 
to wash the cells gently with sterile 1x Phosphate Buffered Saline (PBS) and then allow 
trypsinization using trypsin-EDTA (Cat.No.CC-5012, Lonza, USA). 
 In the seeding phase of the cells, we counted the viable cells via the trypan blue staining, 
where 10μl of trypan blue was mixed with 10μl of cells and finally we used the 
haemocytometer to count the viable cells. Furthermore, we seeded the cells in 96 wells 
micro-plate, polystyrene, flat bottom, clear and sterile (Greiner, Cat.No.EK 25161), 
where the cell count was fixed along the experiments to be about 20 X 103 per well. To 
allow the seeded cells to attach and form confluent sheath, they were incubated at 37 °C 
in a humidified atmosphere of 95% air and 5% CO2 for 24 hours before examining the 
antioxidant activity of TrxATII protein or inducing oxidative stress by different 
concentrations of Hydrogen peroxide (H2O2) on HepG2 cell line.  
11.2.2 MTT Cytotoxicity Assay 
The MTT assay is a well-known colorimetric assay, which is used in assessing the 
viability of cells. This assay is depending on the cellular oxido-reductase enzymes in the 
mitochondrial cells, where they could be an indicator for the existing viable cells. 
Basically, the oxido-reductase enzymes are having the ability to reduce the MTT dye [ 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] to the formazan, which is 
insoluble purple color. The MTT dye characterized by being sensitive to light that is why 
it should be stored in dark place and the assay should be carried out in dark conditions as 
well 81. Thus, to assess the antioxidant role of TrxATII protein, we induced oxidative 
stress conditions on the HepG2 cancer cell line in presence of thioredoxin and 
subsequently, we determined the cell viability using the colorimetric MTT assay. 
Basically, we examined different concentrations of TrxATII (1, 2.5, 5, 10 and 15 μM), 
where each concentration was incubated with the fully attached HepG2 cells for 1 hour 
and then exposed to oxidative stress via different concentrations of H2O2 (100, 200, 800 
and 1600 μM) for further 4 hours. Our control in this experiment was HepG2 cells 
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incubated only with nourishing medium (RPMI 1640, Lonza, USA). The final volume 
that was used in the 96 wells micro-plate for any condition; TrxATII, H2O2 or nourishing 
RPMI media was fixed to be 100 μl per each well. After incubating the seeded HepG2 
cells with different concentrations of thioredoxin for 1 hour followed by incubation with 
different concentrations of H2O2 for further 4 hours, the old media were removed from all 
the 96 wells and replaced by 100 μl RPMI 1640 medium and 20 μl MTT dye 
(Cat.No.20395.01 Serva, Germany) per each well. After that, the 96 wells micro-plate is 
incubated in dark at 37 °C in a humidified atmosphere of 95% air and 5% CO2 for 3 
hours. Consequently, the RPMI 1640 medium containing MTT dye removed from all 96 
wells and replaced by 100 μl DMSO (5mg/ml) to solubilize the purple color precipitate 
(formazan). Using the FLUOstar OPTIMA microplate reader (BMG LabTech, Germany), 
the absorbance of formazan was measured at 590 nm. For further confirmation, each 
examined concentration of TrxATII and H2O2 was done in triplicates and the whole set of 
experiment was done 3 times in 3 different days. Furthermore, to calculate the percentage 
of viable cells, the absorbance of each sample was divided by the absorbance of the 
control and multiplied by 100 as follow: 
 
% of Cell Viability =  Absorbance of Sample   X 100  
                                                 
 
 
Moreover, to detect the changes in the morphology of the HepG2 cell line along the 
experiment conditions, we monitored it microscopically. The used microscope was the 
inverted microscope (Olympus 1X20, USA) under 20x magnification power, where we 
captured photos for different conditions of the cell line; normal control condition 
(incubation with RPMI 1640 medium), oxidative stress condition (incubation with 
different concentrations of H2O2) and oxidative stress condition with prior incubation 
with TrxATII protein. 
 
 
 
Absorbance of Control 
   
 
51 
 
12. Kinetics of TrxATII 
The Trx system as a whole is composed of thioredoxin (Trx), thioredoxin 
reductase (TrxR), and NADPH that serves as a hydrogen donor. Trx is a small 
monomeric protein with its typical active site motif (-Cys–XX–Cys-) that 
catalyzes thiol-disulfide exchange. The oxidized inactive form of Trx (Trx-S2) is 
reduced on the expenses of NADPH through the TrxR. Moreover, the reduced 
active form of Trx (Trx-SH2) catalyzes the reduction of disulfides in oxidized 
proteins as follow 1, 2: 
  
 Trx-S2 + NADPH + H
+ 
                            Trx-SH2 + NADP
+
 
 Trx-SH2 + Protein – S2                             Trx-S2   + Protein – SH2 
 
To obtain the kinetic parameters of Trx system, we have used the DTNB reduction assay. 
We have calculated the kinetic parameters towards two substrates; TrxATII and DTNB. 
For the TrxATII; 100mM phosphate buffer at pH 7.5, 2mM EDTA, 1mM DTNB (Cat. 
No. 20735.02, Serva), TrxATII (0.2-12 µM), 0.1µM E.coli TrxR (Cat. No.TR-01, IMCO 
Corporation Ltd AB) and 200 µM NADPH. For the DTNB; 100 mM phosphate buffer at 
pH 7.5, 2mM EDTA, DTNB (0.01-1mM), TrxATII (4µM), 0.1µM E.coli TrxR, and 200 
µM NADPH. The parameters were calculated from the increase in absorbance at 412 nm, 
where one enzyme unit in the DTNB reduction assay was defined as the NADPH-
dependent production of 2 µmol of 2-nitro-5- thiobenzoic acid per minute  (Ɛ412 = 13.6 
mM-1.cm-1) 82. We have applied Michaelis–Menten equation to calculate the Km (µM) 
and Kcat (S-1), where the Km is the substrate concentration at which the reaction rate is 
half of Vmax (maximum reaction velocity), while the Kcat (turnover number) measures 
the number of substrate molecules turned over per enzyme molecule per second 82. 
 
 
 
 
   TrxR 
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Chapter 3: Results 
 
1. Retrieving TrxATII gene from metagenome of LCL 
TrxATII gene was retrieved directly from the metagenome of the LCL via 
performing PCR with the designed thioredoxin primers on 1x LCL. The PCR product 
was loaded on 0.8% agarose gel electrophoresis. As shown in Figure 22, there is a clear, 
thick and separated band for the TrxATII gene at its proper expected size; ~ 540 bp. To 
perform the following experiments on TrxATII gene, we have excised the TrxATII band 
from the agarose gel and purified it. 
 
 
 
Figure 22: 0.8 % Agarose Gel Electrophoresis for TrxATII gene 
Lane 1; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus DNA 
Ladder (Cat. No. # SM1331). Lane 2 is the metagenome of the 1x LCL showing a clear 
band for TrxATII gene at ~ 540 bp. 
 
 
500 bp 
700 bp 
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2. Recombinant TrxATII Clones (pGEM®-T Easy vector) 
 
Successful cloning of TrxATII gene into the pGEM®-T Easy vector interrupts the 
coding sequence of β-galactosidase enzyme. As shown in Figure 23, successful 
recombinant clones of E. coli Top 10 are recognized by their white colored colonies on 
the indicator plates [LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml) 
agar plates], where twenty clones were picked up  for gene sequencing. On the other 
hand, unsuccessful cloning of TrxATII gene was represented by the blue colonies. 
 
 
 
Figure 23: Recombinant TrxATII Clones of Top 10 E. coli 
Showing recombinant white colonies comprising pGEM vector with thioredoxin insert on 
indicator plates [LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml) agar 
plates], while blue colonies represent the unsuccessful cloning of TrxATII gene. 
 
 
 
 
 IPTG / X-Gal / Ampicillin / LB agar indicator plate
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3. TrxATII gene Sequencing 
3.1 Plasmid Extraction (pGEM®-T Easy Vector) 
To sequence the TrxATII gene, we extracted the pGEM®-T Easy plasmid from 
the picked white colonies, where each picked colony sub-cultured in a separate falcon 
tube containing LB broth/Ampicillin (100μg/ml) overnight at 37°C with shaking at ~ 200 
rpm. For plasmid extraction, we have used the PureYield™ Plasmid Miniprep System 
(Cat.No.A1223, Promega). As shown in Figure 24, the twenty plasmids were analyzed 
on 0.8% agarose gel electrophoresis showing clear bands at the expected size ~ 3540 bp; 
3000 bp for pGEM vector plus 540 bp for TrxATII insert.  
 
 
 
Figure 24: 0.8 % Agarose Gel Electrophoresis for pGEM vector 
comprising TrxATII gene 
 
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus 
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 20 are showing extracted pGEM T 
plasmids comprising TrxATII gene at ~ 3540 bp. 
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For furthermore confirmation, PCR reaction was performed with the previously 
mentioned conditions on the twenty extracted pGEM plasmids using thioredoxin primers 
(Forward and Reverse) and analyzed on 0.8% agarose gel electrophoresis as shown in 
Figure 25. 
 
 
Figure 25: 0.8 % Agarose Gel Electrophoresis for TrxATII gene 
 
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus 
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 20 are showing amplified TrxATII 
gene from pGEM vector at its proper size ~ 540 bp. 
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3.2  Sequence analysis of TrxATII 
TrxATII sequence that has been generated from Applied Biosystems 3730xl DNA 
Analyzer machine was BLASTed against non-redundant (nr) protein databases using 
Basic Local Alignment Search Tool (BLASTP) provided by the National Center for 
Biotechnology Information (NCBI). The protein sequence of TrxATII is shown in Figure 
26.  
 
 
 
Figure 26: Amino acid sequence of TrxATII Vs Prochlorococcus  marinus Trx 
 
The figure is showing the TrxATII sequence, where there are 25 amino acid difference 
(highlighted in red) than the first hit (Prochlorococcus marinus Trx). Additionally, the 
Trx active site (C72: C75) is highlighted in blue color. 
 
Moreover, using ClustalW version 2.1, we have performed a multiple sequence alignment 
of TrxATII with other members of the Trx super family: Prochlorococcus marinus, 
Synechococcus sp, Cyanobium sp, Lyngbya sp., where the alignment showed the 
conserved catalytic active site of Trx Super Family (Figure 27).  
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Figure 27: Conserved Catalytic Active Site of Trx Super Family  
 
Multiple sequence alignment of TrxATII with other members of the Trx super family: 
Prochlorococcus marinus, Synechococcus sp, Cyanobium sp, Lyngbya sp. was performed 
using ClustalW version 2.1. The alignment shows the conserved catalytic active site of 
Trx Super Family, where they have two vicinal cysteines (highlighted in red) comprising 
in between other two amino acids. 
Additionally, a pairwise alignment for TrxATII against the first hit; Prochlorococcus  
marinus Trx (accession number WP_002807427.1) was generated. Interestingly, the 
alignment has shown 25 (14%) amino acids difference. Within the 25 amino acids 
difference, we have noticed that there are 7 acidic residues in TrxATII versus 2 residues 
in Trx Prochlorococcus marinus and 1 basic residue in TrxATII versus 5 residues in 
Prochlorococcus marinus (Figure 28). 
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Figure 28: Alignment of TrxATII with best hit  
 
Alignment with the best hit thioredoxin protein from Prochlorococcus marinus showed 
maximum identity 86%, the highest among all 
 
3.3 3D modeling of Trx (ATII versus Prochlorococcus marinus) 
The 3D modeling of Trx motif has shown the catalytic active site (– Cys
72
 – 
Glu
73
 – Val
74
 – Cys
75
–) (Figure 29). 
Catalytic Active Site 
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Figure 29: 3D modeling of Trx (ATII versus Prochlorococcus marinus) 
The 3D modeling is showing the Trx active site (– Cys
72
 – Glu
73
 – Val
74
 – Cys
75
–) in 
both ATII and Prochlorococcus marinus. Additionally, among the 25 amino acids 
difference between them, there are 7 acidic residues in TrxATII versus 2 residues in Trx 
Prochlorococcus marinus and 1 basic residue in TrxATII versus 5 residues in 
Prochlorococcus marinus. 
 
 
 
 
 
 
 
   
 
60 
 
3.4 Construction of Phylogenetic tree  
The generated phylogenetic tree (Figure 30) showed that TrxATII sequence is 
highly similar to different strains of Prochlorococcus marinus Trx. Table 3 lists the 
sequence identifiers used to compute the tree. The TrxATII is clustered in the clade of 
different strains of Prochlorococcus marinus Trx, which is evidence for the various stress 
conditions at the LCL that requires the TrxATII. Moreover, TrxATII modified to 
accommodate the harsh conditions; thermohalophilicity at the sea bed. 
Figure 30: TrxATII Phylogenetic tree  
 
A Phylogenetic tree for the TrxATII was constructed using CLUSTALW version 2.1 77,78 
. The generated tree is Neighbour-joining tree including the sequences most similar to the 
TrxATII sequence. 
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Table 3: Organisms used in Phylogenetic  tree                                              
  
 
 
Organism Accession Numbers 
Synechococcus sp. CC9605 ref|YP_380605.1| 
Synechococcus sp. WH 8102 ref|NP_896375.1| 
Prochlorococcus marinus str. MIT 9313 ref|NP_895653.1| 
Synechococcus sp. WH 7805 ref|WP_006042318.1| 
Cyanobium sp. PCC 7001 ref|WP_006911410.1| 
Raphidiopsis brookii ref|WP_009341404.1| 
Cylindrospermopsis raciborskii ref|WP_006277703.1| 
Fischerella muscicola ref|WP_016866661.1| 
Richelia intracellularis ref|WP_008234229.1| 
Oscillatoriales cyanobacterium JSC-12 ref|WP_009556771.1| 
Gloeobacter kilaueensis JS1 ref|YP_008713253.1| 
Prochlorococcus marinus subsp. pastoris str. 
CCMP1986 
ref|NP_892361.1| 
Prochlorococcus marinus str. MIT 9515 ref|YP_001010591.1| 
 
Prochlorococcus marinus 
 
ref|WP_002807427.1| 
 
Prochlorococcus marinus str. MIT 9301 
 
ref|YP_001090489.1| 
Prochlorococcus marinus str. MIT 9312 ref|YP_396741.1| 
Prochlorococcus marinus subsp. marinus str. 
CCMP1375 
ref|NP_874666.1| 
 
 
 
 
 
 
 
   
 
62 
 
4.  Transformed TrxATII clones (pET SUMO® Vector) 
Successful cloning of TrxATII gene into the pET SUMO
® 
expression vector, 
allows the growth of the white colonies of the transformed BL21 (DE3) E. coli cells on 
their indicator plates [LB / Kanamycin (50μg/ml)] as shown in Figure 31. 
 
Figure 31: Transformant TrxATII Clones of BL21 (DE3) E. coli 
 
The transformed white colonies are spread on the whole plate, comprising pET SUMO 
vector with TrxATII insert on indicator plates [LB / Kanamycin (50μg/ml)]. 
 
 
 
 
 Kanamycin / LB agar indicator plate
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4.1     Analyzing Transformants 
To analyze the transformed BL21 (DE3) E. coli, PCR reaction was performed on 
five clones, where each picked colony sub-cultured in a separate falcon tube containing 
LB broth/kanamycin (50μg/ml) overnight at 37°C with shaking at ~ 200 rpm. The PCR 
conditions performed as previously mentioned using the thioredoxin primers (Forward 
and Reverse) and analyzed on 0.8% agarose gel electrophoresis. As shown in Figure 32, 
the amplified TrxATII gene band appeared clearly at its proper size ~ 540 bp. in all the 
picked colonies. 
 
Figure 32: 0.8 % Agarose Gel Electrophoresis for TrxATII gene in pET 
SUMO® Vector 
 
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus 
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 5 are showing amplified from 
TrxATII gene from pET SUMO vector at its proper size ~ 540 bp. 
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5. IPTG-inducible Expression of TrxATII 
During the inducible expression of the recombinant TrxATII protein using 
isopropyl β-D-thiogalactoside (IPTG), 4 samples were collected to be analyzed on the 
SDS-PAGE electrophoresis. Moreover, the 4 samples were as follow: E. coli expressed 
proteins before IPTG induction phase, E. coli expressed proteins after IPTG induction 
phase, non-induced E. coli pellets and induced E. coli pellets. As shown in Figure 33, 
both the induced pellets and induced proteins showed  more intensified bands for 
TrxATII protein at its proper size ~ 12 KDa rather than that of  the non-induced pellets 
and proteins. 
 
Figure 33: SDS-PAGE Electrophoresis for induced and non-induced TrxATII 
 
Lane A and B show ProSieve®Color Protein Markers (Cat. No.50550, Lonza).  
Lane 1 shows E. coli non-induced TrxATII overnight.  
Lane 2 shows E. coli induced TrxATII overnight.  
Lane 3 shows E. coli induced TrxATII over 2 hours.  
Lane 4 shows E. coli non-induced pellets.  
Lane 5 shows E. coli induced pellets over 2 hours. 
Lane 6 shows E. coli induced pellets overnight. 
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6. Purified TrxATII fractions 
Purification of recombinant TrxATII protein was done against metal-chelating 
resin (Ni-NTA agarose resin, Cat.No.R901-15, Invitrogen™), where the Ni-NTA resin 
has high affinity and selectivity for 6xHis-tagged recombinant TrxATII protein. Different 
samples of purified TrxATII were taken for SDS-PAGE electrophoresis analysis. As 
shown in Figure 34, all E. coli proteins were washed out, while different fractions of 
the recombinant TrxATII protein was eluted and purified.  
 
Figure 34: SDS-PAGE Electrophoresis for purified fractions of  TrxATII 
 
Lane A shows ProSieve®Color Protein Markers (Cat. No.50550, Lonza), while Lanes 
from 1 to 9 show purified fractions of TrxATII at ~ 16 KDa. 
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7. Quantification of TrxATII fractions 
After dialysis, we quantified the concentration of TrxATII protein in each eluted 
fraction using the Thermo Scientific Pierce BCA Protein Assay (Cat.No.23225, Thermo 
SCIENTIFIC). As shown in Figure 35, we have got different concentrations for TrxATII 
fractions from different induction batches, where the highest concentration was 1303 
μl/ml. 
 
 
Figure 35: Quantification of TrxATII concentration 
Using the Thermo Scientific Pierce BCA Protein Assay kit (Cat.No.23225, Thermo 
SCIENTIFIC), different concentrations for TrxATII fractions from different induction 
batches have been quantified after plotting the standard curve of BSA; 1303ug/ml, 216 
ug/ml, 168 ug/ml and 125 ug/ml. 
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8. Cell Culture and MTT Assay 
 
The oxidative stress conditions applied on the cell culture of the cancerous HepG2 
cell line after pretreatment with different concentrations of the antioxidant TrxATII 
protein was maintained to assess the antioxidant role of TrxATII via MTT assay.  After, 
the HepG2 cell line reached a confluence stage (after 24 hours incubation), we induced 
oxidative stress via different concentrations of H2O2 (100, 200, 800 and 1600 μM) for 4 
hours. Additionally, we induced oxidative stress condition with the same concentrations 
of H2O2, but after the prior exposure to different TrxATII concentrations (1, 2.5 and 5 
μM) for 1 hour. Morphologically under the inverted microscope and 20X magnification 
power, HepG2 cells show full attachment after 24 hours incubation with RPMI 1640 
media as shown in Figure 36 A, while the cells detached and became more rounded upon 
incubation with different concentration of H2O2 (100, 200, 800 and 1600 μM) for 4 hours 
as shown in Figure 36 B1, C1, D1 and E1. Moreover, the pre-incubation of the HepG2 
cells with TrxATII protein (5 μM) for 1 hour prior oxidative stress induction, shows less 
detachment with much better survival rather than the oxidative stress conditions only as 
shown in Figure 36 B2, C2, D2 and E2. Although, we have examined different 
concentrations of TrxATII protein (1, 2.5, 5μM), the optimum antioxidant concentration 
that reduced the oxidative stress and showed better cell survival percentage was the 5 
μM. Furthermore, in the MTT assay, the exposure of the HepG2 cells to 5μM TrxATII 
for 1 hour prior the oxidative stress exposure for 4 hours showed survival advantage as 
shown in Figure 37. At 100μM, 200μM, 800μM and 1600μM H2O2, the survival were 
87%, 64%, 8% and 3.5% respectively. On the other hand, the pretreatment with 5μM 
TrxATII improved the survival to 89%, 69%, 10.7% and 8.8 respectively (Figure 37). 
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                              A 
 
 
B 1                                                                   B 2 
                                                       
 
C 1                                                                   C 2 
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D 1                                                                   D 2 
                                                       
E 1                                                                   E 2 
                                                      
Figure 36: Morphology of HepG2 cells upon induction of oxidative stress conditions using  
                      H2O2 (100μM, 200 μM, 800 μM and 1600 μM) in presence and absence of  
                      5μM TrxATII under 20x magnification power. 
 
(A )  Confluent sheath of HepG2 cells after 24 hours incubation in RPMI 1640 media.  
(B1) HepG2 cells after 4 hours incubation with 100μM H2O2 
(B2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 100μM H2O2 
(C1) HepG2 cells after 4 hours incubation with 200μM H2O2 
(C2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 200μM H2O2 
(D1) HepG2 cells after 4 hours incubation with 800μM H2O2 
(D2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 800μM H2O2 
(E1) HepG2 cells after 4 hours incubation with 1600μM H2O2 
(E2) HepG2 cells after 1 hour exposure to5μM TrxATII then 4 hours incubation with 1600μM H2O2 
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Figure 37: Effect of 5uM TrxATII in reducing Oxidative Stress induced 
on HepG2 
Cell survival of HepG2 cells after exposure to oxidative stress conditions for 4 hrs, as per 
MTT assay. Left to right: (1) Control untreated HepG2 cells, (2) 100uM H2O2, (3) 
200uM H2O2, (4) 800uM H2O2, and (5) 1600uM H2O2. The presented data are mean of 
three independent experiments, where each concentration is mean of three. The p-value = 
1.506 E-12 and the p-value range < 0.001 were computed by ANOVA R© version 2.14.1, 
a statistical analysis program.  
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9. Redox Activity and Characterization of TrxATII 
9.1     Redox Activity at room temperature 
          To examine the redox activity of TrxATII, we have performed the insulin 
reduction assay at room temperature as described in the materials and methods. As shown 
in Figure 38, the absorbance increased rapidly at 650 nm, demonstrating the successful 
reduction of insulin via disulfide bond exchange with TrxATII. 
 
 
Figure 38: Redox activity of TrxATII at room temperatures       
 
The redox activity of TrxATII was assayed at room temperature via insulin reduction 
assay, where the aggregation of insulin was measured spectrophotomerically at 650 nm. It 
is clear that the absorbance increased rapidly until the insulin consumed, then formed a 
plateau. 
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9.2     Thermostability 
 The effect of increasing temperature on the activity of TrxATII was assayed, where 
Trx was incubated at range of temperatures (25oC to 80oC) for 10 minutes after which the 
residual activity was assessed by the insulin reduction assay, where the aggregation of 
insulin was measured spectrophotomerically at 650 nm. As shown in Figure 39, the 
residual activity of TrxATII was 100 %, 100 %, 97.23 %, 90.59 %, 65.57 %, and 10.25% 
at 25 ᵒC, 37 ᵒC, 50 ᵒC, 60 ᵒC, 70 ᵒC, and 80 ᵒC respectively. 
 
Figure 39: Redox activity of TrxATII at different temperatures       
                   (Thermostability) 
After incubating thioredoxin at different temperatures (25 ᵒC – 80 ᵒC), the residual 
activity of thioredoxin was assayed via insulin reduction assay, where the aggregation of 
insulin was measured spectrophotomerically at 650 nm. It is clear that the residual 
activity of thioredoxin was 100 %, 100 %, 97.23 %, 90.59 %, 65.57 %, and 10.25 % at 25 
ᵒC, 37 ᵒC, 50 ᵒC, 60 ᵒC, 70 ᵒC, and 80 ᵒC respectively. 
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9.3      Halophilicity  
The effect of NaCl concentration on the redox activity of TrxATII was assayed at 
different molar concentrations of NaCl (0.5M – 4M) using the insulin reduction assay. As 
Shown in Figure 40, the redox activity of TrxATII increased gradually from 6.09 
uM/min/mg at 0.5M NaCl to reach its maximum (30.15 uM/min/mg) at 2.5M NaCl, and 
then shows gradual decrease in redox activity till the lowest activity (0.54 uM/min/mg) at 
4M NaCl.  
 
 
Figure 40: Redox activity of TrxATII at different NaCl molar 
concentrations (Halophilicity) 
 
The effect of NaCl concentration on the redox activity of TrxATII was assayed at 
concentrations 0.5M – 4M using the insulin reduction assay. The redox activity of 
TrxATII increased gradually from 6.09 uM/min/mg at 0.5M NaCl to reach its 
maximum (30.15 uM/min/mg) at 2.5M NaCl, and then shows gradual decrease in 
redox activity till the lowest activity (0.54 uM/min/mg) at 4M NaCl.  
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10. Kinetic parameters of TrxATII 
The kinetic parameters were determined (shown in Table 4) as described in 
Materials and Methods. The Km and Kcat for TrxATII was 1.23 µM and 25.74 S-1 
respectively, while the Km and Kcat for DTNB was 95.72 µM and 15.34 S-1 respectively. 
By comparing our kinetic parameters versus other thermostable Trx system; aerobic 
hyperthermophilic archaeon Aeropyrum pernix K1, the Km and Kcat for Trx was 12.3 
µM and 63.2 S-1 respectively, while the Km and Kcat for DTNB was 172.4 µM and 9 S-1 
respectively83. Thus, it is clear that the number of Aeropyrum pernix Trx molecules 
turned over per enzyme molecule per second (63.2 S-1) is more than double of that of 
TrxATII (25.74 S-1). Basically, the reason behind that is the source of TrxR used in our 
DTNB assay, where it is form E.coli source (Cat. No.TR-01, IMCO Corporation Ltd AB) 
and not from the same environment of TrxATII; Atlantis II brine pool, which could lead 
to a kind of incompatibility.  
 
Table 4: Kinetics of TrxATII using DTNB assay 
    Assay           Substrate Km (µM) Kcat (S-1) 
DTNB TrxATII 
(0.2-12 µM) 
1.23 25.74 
DTNB DTNB 
(0.01-1 mM) 
95.72 15.34 
 
The kinetic parameters were determined as described in Materials and Methods. 
The Km value for TrxATII was determined at 0.2 – 12 µM TrxATII and 1 mM 
DTNB. Moreover, the Km value for DTNB was determined at 0.01 – 1 mM 
DTNB and 4 µM TrxATII. 
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Chapter 4: Discussion 
In this thesis work, we have characterized a novel thermohalophilic antioxidant 
TrxATII from the metagenome of the Lower Convective Layer (LCL) of the 
Atlantis II Deep brine pool in the Red Sea. Basically, the Atlantis II Deep is the 
biggest discovered brine pool in the Red Sea until now, about 6 x 13 Km 11 . The 
environment of the LCL has unusual blend of tough conditions; extremely high 
temperature that reaches 68.2°C, salinity of about 26%, which is 7.5 folds more 
than that of other seas and its pH value is 5.3 5, 10. Furthermore, the LCL of 
Atlantis II Deep is almost oxygen depleted environment (anoxic) and highly 
enriched with sulfides of iron, zinc, copper and other heavy metals, in addition 
to high value metals as silver, cobalt and gold 9, 10, 11.  That is why; it is very 
attractive spot to understand the structural and functional modifications of 
enzymes and proteins that have been adapted in sake of survival of the microbial 
communities in these harsh abiotic conditions, in addition to the expectation to 
discover novel genes, proteins and metabolic pathways that can be conveniently 
applied in the industry of biotechnology or pharmaceuticals. In this study, we 
have characterized TrxATII. To the best of our knowledge, this is first attempt to 
mine for thioredoxin protein from the Atlantis II Deep.   
TrxATII gene was retrieved directly from the metagenome of the LCL. For 
further characterization of TrxATII, we have induced high quantities via sub-cloning into 
a high copy number vector (pGEM®-T Easy), where we have selected the recombinant 
clones (White/Blue Screening) to be further analyzed and sequenced to identify the 
TrxATII.  Futhermore, TrxATII similarity search against NCBI non-redundant protein 
database was done using the BLASTP (2.2.29)98 (NCBI). The first best hit was 
thioredoxin protein from Prochlorococcus marinus [str. MIT 9202] (thioredoxin family 
protein) (Accession: WP_002807427.1) with maximum identity 86%, similarity up to 
92% and coverage 98% of the query length, (Figure 40). Other hits were from other 
strains of Prochlorococcus marinus; MIT 9215, MIT 301, MIT 312, MIT 515, and AS 
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9601 as well as other species;  Synechoccus sp (identity 44%), Richelia sp (identity 37%),  
Oscillatoriales sp. (identity 34%), Lyngbya sp. (identity 34%), Cylindrospermopsis sp 
(identity 33%),  
Moreover, TrxATII protein’s sequence showed the thioredoxin motif; two vicinal 
Cysteines comprising two amino acids in-between (CEVC), with the maximum identity 
of 86% with Prochlorococcus marinus (first hit). Interestingly, the TrxATII amino acid 
sequence differs from the first hit (Trx of Prochlorococcus marinus) by 14 % represented 
by 25 amino acids that changed the thermo-halophilicity properties of the protein, where 
the TrxATII has extra 7 acidic residues. Subsequently, upon performing activity assay of 
TrxATII, it showed redox activity at wide range of temperatures (25oC to 80oC) and at 
different molar concentrations of NaCl (0.5 – 4 M).  In conclusion, it is clear that there is 
various stress conditions at the LCL of ATII that requires the presence of Trx. Moreover, 
TrxATII has been modified to accommodate the unique harsh condition at the LCL of 
Atlantis II brine pool at Red Sea via its thermo-halophilic nature. 
 This work supports the potentiality of the metagenomic approaches in identifying 
novel proteins with unique characteristics and potential applications from communities 
inhabiting extreme environments.  
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Chapter 5: Conclusion and Future Prospects 
In conclusion, we have identified a novel TrxATII protein from the Atlantis II 
brine pool in the Red Sea. Sequence analysis of TrxATII revealed its difference from 
other thioredoxins, which has high impact on its thermophilic and halophilic 
characteristics. We are recommending further characterization of TrxRATII to understand 
the whole thioredoxin system at the Atlantis II brine pool. 
 
Moreover, there is a room for research that could be conducted to complement this study. 
Basically, different points should be addressed;  
1- Will the combination of the TrxRATII with the TrxATII improve the antioxidant 
profile of the whole Trx system? 
2- During the in vitro assay of the TrxATII on the HepG2 cells, we introduced 
TrxATII to the cell culture. Does the cloning of both TrxATII gene and TrxRATII within 
the genome of the cell line improve the antioxidation profile (to implement the whole Trx 
system from ATII)?  
3- If we examined another cell line, will the antioxidation activity of TrxATII be 
altered? 
 
To wrap up, using recombinant TrxATII could have a wide range of potential therapeutic 
applications in different oxidative stress conditions as in cancer, which should be 
examined in various animal models as a potential antioxidant candidate. 
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